Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1050.Time spend outdoors in summer,44997,-0.0159714989427823,0.0232157220363992,-0.0614743141341248,0.0295313162485601,0.491481225146664
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1060.Time spent outdoors in winter,39254,0.00336266621935777,0.0265003675804112,-0.0485780542382481,0.0553033866769637,0.899027078971676
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1070.Time spent watching television (TV),47304,0.0354869616548185,0.0240596756271497,-0.011670002574395,0.082643925884032,0.140231044783897
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1080.Time spent using computer,39233,-0.0134744414354793,0.0246829800476972,-0.0618530823289658,0.0349041994580072,0.585137710264471
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1090.Time spent driving,34011,-0.0111537323615889,0.0276176205254768,-0.0652842685915233,0.0429768038683456,0.686316078498734
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1160.Sleep duration,49861,0.0279345467228948,0.0217560027524547,-0.0147072186719164,0.0705763121177059,0.199150509808284
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,16690,-0.0059103833121309,0.00954085160960806,-0.0246104524669627,0.0127896858427009,0.535607513858491
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,16690,-0.0146178755712554,0.00932064336694438,-0.0328863365704664,0.00365058542795554,0.116822336793767
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,16690,0.0125269475279449,0.010653127354314,-0.0083531820865106,0.0334070771424005,0.239654061476554
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,16690,0.00853134956221578,0.0108764090040218,-0.012786412085667,0.0298491112100985,0.432822278736495
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,16690,-0.00357690405029849,0.0110809313140893,-0.0252955294259134,0.0181417213253165,0.746852166531074
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,16690,0.0191391018933533,0.0234705101576078,-0.026863098015558,0.0651413018022645,0.414824606795735
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,16690,0.0134667203546629,0.0244899359945024,-0.0345335541945617,0.0614669949038875,0.5824036036767
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,16690,0.013711421276252,0.0167004859427385,-0.0190215311715155,0.0464443737240195,0.411647011458306
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,16690,0.00345126164472867,0.01227909631372,-0.0206157671301626,0.0275182904196199,0.778661693989903
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,16690,-0.00167657245186496,0.00840944471560314,-0.0181590840944471,0.0148059391907172,0.84197748120929
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#18.Location of pain during the past week_Upper back,16690,-0.0201226769154916,0.0121871848228525,-0.0440095591682826,0.00376420533729939,0.0987300174992816
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#19.Location of pain during the past week_Lower back,16690,-0.00646928115577628,0.00681182227291535,-0.0198204528106904,0.00688189049913781,0.342271493259301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,16690,-0.0136864768820118,0.0088248615253507,-0.0309832054716992,0.00361025170767557,0.120944650376481
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,16690,0.00705891099815553,0.0130794581426025,-0.0185768269613454,0.0326946489576565,0.589414972637925
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,16690,0.00717127958495968,0.0124087520754133,-0.0171498744828504,0.0314924336527697,0.563325195913964
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,16690,0.00919314405242444,0.0165000211189697,-0.0231468973407562,0.041533185445605,0.577425913502453
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,16690,-0.0111941612416363,0.0155611530788562,-0.0416940212761944,0.0193056987929219,0.471925647487102
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#7.Location of pain during the past week_Left hip,16690,-0.000382825873306903,0.00954818506097066,-0.0190972685928094,0.0183316168461956,0.968018586623335
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#8.Location of pain during the past week_Right hip,16690,0.0141254245330704,0.00908879029666598,-0.0036886044483949,0.0319394535145357,0.120165489926227
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,16690,0.00807940894742446,0.0112976949824395,-0.014064073218157,0.030222891113006,0.474533898745778
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120040.Fatigue severity over the past week,16703,-0.0361940120258896,0.0406839784346712,-0.115934609757845,0.0435465857060659,0.373673135478745
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120041.Waking unrefreshed severity over the past week,16703,-0.0428513091592867,0.0396045404225535,-0.120476208387492,0.0347735900689181,0.279277178906563
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120042.Cognitive symptoms severity over the past week,16702,-0.0645893992338166,0.0438649897688061,-0.150564779180677,0.0213859807130433,0.140915830229164
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120098.Mobility problems today,16711,0.0113895118709128,0.0469005473854103,-0.0805355610044914,0.103314584746317,0.80812930896113
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120099.Self-care problems today,16711,0.0058163880688211,0.0715042795492496,-0.134331999847708,0.14596477598535,0.935169981436897
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120100.Problems doing usual activities,16711,0.0267533971259198,0.0443739404034483,-0.0602195260648389,0.113726320316679,0.546578181749037
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120101.Pain or discomfort today,16711,-0.0284585618550799,0.0400729210396435,-0.107001487092781,0.0500843633826213,0.477609020702349
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120102.Anxiety or depression today,16711,-0.048756092404086,0.0495771611825979,-0.145927328321978,0.048415143513806,0.325405888416011
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120103.Scale to indicate how health is today,16656,-0.00206389878244421,0.00295809440941865,-0.00786176382490477,0.00373396626001635,0.485366896991396
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,16671,-0.0649110471233442,0.0502307789379687,-0.163363373841763,0.0335412795950745,0.196286283872335
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",16649,-0.04247318756138,0.0510883846478698,-0.142606421471205,0.0576600463484448,0.405778375028903
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",16681,-0.0399114867035216,0.0396754949173959,-0.117675456741618,0.0378524833345743,0.314455166713739
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,16682,-0.026144945153187,0.0406143353917767,-0.105749042521069,0.0534591522146953,0.519754934863834
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,16688,-0.0203634677830142,0.0532158160139285,-0.124666467170314,0.0839395316042856,0.70197809747089
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120109.Feeling bad about self over the last two weeks,16644,-0.0126486603923281,0.0531299137145603,-0.116783291272866,0.0914859704882101,0.811829417085483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120110.Trouble concentrating over the last two weeks,16688,-0.015629362470368,0.052808039897637,-0.119133120669737,0.0878743957290005,0.767260049228188
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,16671,-0.0374265007113054,0.0793015425634978,-0.192857524135761,0.11800452271315,0.636967421430366
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,16601,-0.188640328571254,0.121264028629411,-0.426317824684899,0.0490371675423922,0.119818384248368
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11616,0.0537379204589559,0.053707194534429,-0.0515281808285249,0.159004021746437,0.317054594835097
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45096,-0.0716288792003345,0.0577349542997801,-0.184789389627904,0.0415316312272346,0.214741476895176
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,42084,-0.0436827330158892,0.0340785030739587,-0.110476599040848,0.0231111330090699,0.199910531804171
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1289.Cooked vegetable intake,48423,-0.00985492796779907,0.0225351231733287,-0.0540237693875233,0.0343139134519252,0.661885494308944
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47109,0.0216586640661254,0.0240808800844903,-0.0255398608994756,0.0688571890317265,0.368437150912575
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1309.Fresh fruit intake,48313,-0.0100712523295627,0.023721559351406,-0.0565655086583184,0.036423003999193,0.671158516011291
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1319.Dried fruit intake,45635,-0.0249834590187962,0.0243732124108277,-0.0727549553440185,0.0227880373064261,0.305350884337269
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X134.Number of self-reported cancers,50291,-0.0624245546387134,0.0443105411463164,-0.149273215285494,0.0244241060080667,0.158901405755467
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X135.Number of self-reported non-cancer illnesses,50292,-0.0259081293757117,0.0223898054059551,-0.0697921479713837,0.0179758892199604,0.247220847432368
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X136.Number of operations, self-reported",50292,-0.0272017853640684,0.022357189905599,-0.0710218775790425,0.0166183068509056,0.223727624696439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X137.Number of treatments or medications taken,50292,-0.0360345031519233,0.02197025048238,-0.0790961940973882,0.00702718779354149,0.100980268337167
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1438.Bread intake,48817,-0.000730094637624543,0.0018384341315313,-0.00433342553542589,0.0028732362601768,0.69127442154913
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1458.Cereal intake,47753,-0.0182809015801245,0.0225600284425238,-0.0624985573274711,0.0259367541672221,0.417758811678187
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1488.Tea intake,48531,-0.00304159990128352,0.00175820403498704,-0.00648767980985813,0.000404480007291084,0.0836460937529693
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1498.Coffee intake,46337,0.0199739477754764,0.0224101170404711,-0.0239498816238468,0.0638977771747997,0.372777414397204
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1528.Water intake,46484,0.0328884630236264,0.0234206937128837,-0.0130160966536257,0.0787930227008784,0.160251687200312
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1568.Average weekly red wine intake,34237,0.046130446354376,0.0263254042362214,-0.0054673459486179,0.0977282386573698,0.0797283154250398
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,34231,0.0346997975360897,0.0264903953603478,-0.0172213773701919,0.0866209724423714,0.190238095471414
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1588.Average weekly beer plus cider intake,34322,0.0220287373250527,0.03000178976243,-0.03677477060931,0.0808322452594154,0.462802963287976
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1598.Average weekly spirits intake,34177,-0.0171483475668371,0.0288301523789149,-0.0736554462295103,0.0393587510958361,0.551977097051136
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1608.Average weekly fortified wine intake,34297,0.118935434060352,0.043302482598427,0.0340625681674352,0.203808299953269,0.00602444024506598
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1737.Childhood sunburn occasions,37734,-0.0455301586364117,0.0267988514472579,-0.0980559074730372,0.00699559020021377,0.0893350937849507
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1807.Father's age at death,37019,-0.000511237095878061,0.0020312249888041,-0.0044924380739341,0.00346996388217798,0.801282816006188
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1845.Mother's age,19119,-0.00577605619546561,0.00480956107085825,-0.0152027958943478,0.00365068350341657,0.229784370769701
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1873.Number of full brothers,49381,-0.0418157580351684,0.0214959776969317,-0.0839478743211545,0.000316358250817661,0.0517466072012662
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1883.Number of full sisters,49388,-0.0104283352877027,0.021554868273094,-0.0526758771029669,0.0318192065275616,0.628526996681279
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20015.Sitting height,49898,0.00370107018743457,0.00230413557494055,-0.000815035539448902,0.00821717591431804,0.108220324329155
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20016.Fluid intelligence score,16121,0.0307059622557889,0.0359350902960383,-0.0397268147244461,0.101138739236024,0.392849549542183
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20018.Prospective memory result,16795,0.0675707027958881,0.0446972654115554,-0.0200359374107605,0.155177343002537,0.130618515248386
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),15910,-0.00211255998952983,0.00332195550943737,-0.00862359278802707,0.00439847280896741,0.524825548171003
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),15894,-0.000266874203030562,0.00330594449154522,-0.0067465254064592,0.00621277700039807,0.935661230675851
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20023.Mean time to correctly identify matches,49683,0.000496743600381464,0.00185018398373647,-0.00312961700774202,0.00412310420850494,0.788328401743627
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#1.Illnesses of father_Heart disease,43740,-0.00677333032912266,0.0039559016305884,-0.0145268975250759,0.000980236866830617,0.0868652520006875
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,42867,0.000249728194129004,0.00873289736863285,-0.0168667506483914,0.0173662070366494,0.977186728991691
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,42799,-0.00692482245124778,0.0117031324672938,-0.0298629620871436,0.0160133171846481,0.55405010355981
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#12.Illnesses of father_Severe depression,42837,0.0171641365627211,0.00989676251200187,-0.0022335179608026,0.0365617910862447,0.0828688142349797
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,42861,0.00386144815319917,0.0070547513492118,-0.00996586449125595,0.0176887607976543,0.584138228816408
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#2.Illnesses of father_Stroke,43197,-0.00731716966899679,0.00509710870240748,-0.0173075027257155,0.00267316338772187,0.151136820990049
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#3.Illnesses of father_Lung cancer,43078,0.00687415888446083,0.00650097742034159,-0.00586775685940869,0.0196160746283304,0.290333223350318
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,42883,-0.00651166485446522,0.00805707697900945,-0.0223035357333237,0.0092802060243933,0.418984568733302
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,43159,-0.00594233790337385,0.00589235012642669,-0.0174913441511702,0.00560666834442247,0.313228058597595
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#8.Illnesses of father_High blood pressure,43301,-0.00838717714186354,0.00443554931360782,-0.0170808537965349,0.000306499512807779,0.0586444578920216
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#9.Illnesses of father_Diabetes,43035,-0.00348622700678811,0.0061549981118657,-0.0155500233060449,0.00857756929246866,0.571120865847328
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45864,-0.00302853785922837,0.00449057385116694,-0.0118300626075156,0.00577298688905884,0.500047017604432
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45577,-0.00584576058672476,0.00643911703880339,-0.0184664299827794,0.00677490880932987,0.363961607424668
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45435,0.00875232462457837,0.0139150810538983,-0.0185212342410622,0.0360258834902189,0.529364515835915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45504,0.000369254179387401,0.00720418397416806,-0.013750946409982,0.0144894547687568,0.959122138242222
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#2.Illnesses of mother_Stroke,45741,-0.00110104899457891,0.00510925690383537,-0.0111151925260962,0.00891309453693841,0.829377842768429
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45531,-0.00564766618189367,0.00906009940024032,-0.0234054610063647,0.0121101286425774,0.533053811485519
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45491,-0.00138139802464031,0.0080960607592566,-0.0172496771127833,0.0144868810635026,0.864518654313532
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45532,0.00821679097039026,0.00658267492213433,-0.00468525187699302,0.0211188338177735,0.211947774469196
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45583,0.0146111943225392,0.007574759310624,-0.000235333926283887,0.0294577225713622,0.0537455287530094
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45935,-0.000675697333604376,0.00387585225423473,-0.00827236775190445,0.0069209730846957,0.861602834974426
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45646,0.00272421877638326,0.00598883708576411,-0.00901390191171438,0.0144623394644809,0.6491957463489
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,39332,-0.00488340818436974,0.00638981709427864,-0.0174074496891559,0.00764063332041639,0.444723750364522
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,39048,-0.00517220924206575,0.0255509949112711,-0.055252159268157,0.0449077407840255,0.839584038669647
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,39036,-0.0354324910770606,0.0258158258169384,-0.0860315096782599,0.0151665275241386,0.169912471948613
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,39156,-0.00958967144788132,0.00752884231646932,-0.0243462023881612,0.00516685949239855,0.202768608672233
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,39070,-0.00858043228149488,0.0149435187149376,-0.0378697289627726,0.0207088643997829,0.565841941471106
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#2.Illnesses of siblings_Stroke,39116,-0.00513782348915758,0.0107805170209704,-0.0262676368502595,0.0159919898719443,0.633660938717956
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,39068,-0.00767961357775589,0.012800345140949,-0.032768290054016,0.0174090628985042,0.548540617718845
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,39071,-0.0184157929295587,0.0125233061100962,-0.0429614729053472,0.00612988704622978,0.141428578648363
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,39095,-0.00282628976242457,0.00939907319271466,-0.0212484732201453,0.0155958936952962,0.763645805218392
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,39115,-0.00290067931723505,0.0115838863318959,-0.0256050965277511,0.019803737893281,0.802274393527579
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,39469,-0.00508926859160993,0.004773947923546,-0.0144462065217601,0.00426766933854022,0.286407430190298
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,39253,-0.00732212701969537,0.00678013843664502,-0.0206111983555196,0.00596694431612887,0.280176567309676
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20127.Neuroticism score,39968,0.00962032113915857,0.0227520683939887,-0.0349737329130592,0.0542143751913764,0.672419519736629
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16121,0.0137967154082471,0.0348676841045723,-0.0545439454367146,0.0821373762532087,0.692340639175324
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X20161.Pack years of smoking,15312,0.00200036784877409,0.00341486579985466,-0.00469276911894105,0.00869350481648922,0.558030479560102
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15312,0.00161368764915866,0.00336890567746505,-0.00498936747867285,0.00821674277699016,0.631949311965027
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20191.Fluid intelligence score,12437,-0.0196867478985018,0.0404830888244658,-0.0990336019944549,0.0596601061974512,0.626766185942919
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12438,-0.00790900632814957,0.0405892494475986,-0.0874639352454429,0.0716459225891437,0.845509881868547
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20240.Maximum digits remembered correctly,11178,-0.0254417657106084,0.0423995737356563,-0.108544930232495,0.0576613988112779,0.548486649614666
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20255.Spirometry QC measure,37418,0.0243924032131668,0.0285713082045226,-0.0316073608676974,0.080392167294031,0.393255802354492
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X20261.avMSE,11018,0.0112324708258764,0.00386576961234233,0.00365556238568548,0.0188093792660674,0.00367252678362845
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X20262.Myopia diagnosis,11018,-0.121030137637723,0.0569986331145617,-0.232747458542264,-0.00931281673318177,0.0337437179668899
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X20280.Glucose-lactate,28725,0.00179587647640485,0.0023853951840592,-0.00287949808435119,0.00647125103716088,0.451538240022198
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X20281.Spectrometer-corrected alanine,28788,0.00182037555210771,0.00239488555958796,-0.00287360014468468,0.00651435124890011,0.447195290761719
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,15715,0.0104273385120455,0.0121789173619468,-0.0134433395173702,0.0342980165414613,0.391911605248109
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,15712,0.00656914716093404,0.0238307065087676,-0.0401390375962505,0.0532773319181186,0.782813667923263
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),15710,0.0174156784586,0.029377884722497,-0.0401649755974941,0.0749963325146942,0.553312876929891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),15710,0.0010852769211029,0.0115494221090241,-0.0215515904125843,0.0237221442547901,0.925135719241276
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),15710,0.0234807308858435,0.0200907737630595,-0.015897185689753,0.0628586474614401,0.242529360982156
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,15721,-0.00589696716180016,0.0255754726633618,-0.0560248935819893,0.0442309592583889,0.81765095465227
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,15721,-0.00220615906094683,0.0167238399019978,-0.0349848852688626,0.0305725671469689,0.895051618847694
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,15721,-0.0180456432982153,0.0187506024055325,-0.054796824013059,0.0187055374166284,0.33586182756121
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,15721,-0.0218555144965751,0.0289256627096101,-0.0785498134074109,0.0348387844142607,0.449915236853257
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,15721,-0.0231551726760595,0.0334562711202944,-0.0887294640718365,0.0424191187197174,0.488883121355569
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,15721,-0.0174196468570077,0.0195062215053775,-0.0556518410075476,0.0208125472935321,0.371854627941436
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,15721,-0.0161748537630155,0.0329617473405497,-0.0807798785504929,0.0484301710244619,0.623634249065904
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,15721,-0.0125598313632866,0.0247132406727972,-0.0609977830819691,0.035878120355396,0.611304268873034
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),15722,0.0125093587029629,0.0336975214985488,-0.0535377834341928,0.0785565008401187,0.710475042706722
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),15722,-0.00412117032313411,0.0154846540767366,-0.0344710923135379,0.0262287516672697,0.790130681172329
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),15722,-0.000354020513364913,0.0232297596777739,-0.0458843494818017,0.0451763084550719,0.987840938697003
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,15724,-0.0353258547555984,0.038980746587605,-0.111728118067304,0.0410764085561075,0.364823508499818
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20600.Liking for adding salt to foods,18192,-0.00567451485449459,0.0349962768490315,-0.0742672174785963,0.0629181877696071,0.871192493419509
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20601.Liking for aniseed,18192,-0.0616871729487837,0.0350869496385724,-0.130457594240386,0.00708324834281811,0.0787434196538414
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20602.Liking for apple juice,18192,-0.019024717667982,0.0350660232046445,-0.0877541231490853,0.0497046878131212,0.587453264358777
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20603.Liking for apples,18192,0.00223485280079267,0.0355562656051373,-0.0674554277852765,0.0719251333868618,0.949883472531777
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20604.Liking for asparagus,18192,0.0352778511437909,0.0345889927526487,-0.0325165746514005,0.103072276938982,0.307782099973372
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20605.Liking for aubergine,18192,0.00397726362242144,0.0335568758206479,-0.0617942129860485,0.0697487402308913,0.905654534511932
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20606.Liking for avocados,18192,0.0267547554107588,0.0344971358611711,-0.0408596308771365,0.0943691416986542,0.438016236808614
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20607.Liking for bacon,18192,-0.00636020231442245,0.0344565793407967,-0.073895097822384,0.0611746931935391,0.853555824118831
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20608.Liking for baked or steamed fish,18192,-0.0370763251619846,0.0345348469726593,-0.104764625228397,0.0306119749044277,0.283019976144827
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20609.Liking for bananas,18192,-0.0162791398191676,0.0344666419610224,-0.0838337580627714,0.0512754784244362,0.636707061904921
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18192,0.0242288268195586,0.0342186741855408,-0.0428397745841013,0.0912974282232185,0.478917945474446
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20611.Liking for beef steak,18192,0.0419753003297291,0.0348954020129174,-0.0264196876155891,0.110370288275047,0.229034895529735
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20612.Liking for beetroot,18192,-0.0171791587098627,0.0340692294815083,-0.083954848493619,0.0495965310738937,0.614096984193677
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20613.Liking for bell pepper,18192,0.0159332220955865,0.0346510096507845,-0.0519827568199511,0.083849201011124,0.645651035293249
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20614.Liking for bicycling,18192,-0.100340965160625,0.0352873273442657,-0.169504126755386,-0.0311778035658646,0.00446650410879345
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20615.Liking for biscuits,18192,0.0326096782310229,0.034933960123022,-0.0358608836101001,0.101080240072146,0.350591612044075
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20616.Liking for bitter foods,18192,-0.0251470336195912,0.033960300735018,-0.0917092230602265,0.041415155821044,0.459016394021097
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20617.Liking for bitter or ale,18192,-0.018083636422467,0.0351783597626251,-0.0870332215572122,0.0508659487122781,0.607219298995076
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20618.Liking for black olives,18192,-0.00866913324732544,0.0337927253908735,-0.0749028750134375,0.0575646085187866,0.797538002655334
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20619.Liking for black pepper,18192,0.0179274613258303,0.0343215681215801,-0.0493428121924666,0.0851977348441273,0.601441341949942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20620.Liking for blue cheese,18192,-0.000883986725527099,0.0346626134651848,-0.0688227091172894,0.0670547356662352,0.979654355671092
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20621.Liking for bolognese sauce,18192,0.00721209759559863,0.034865509727005,-0.0611243014693311,0.0755484966605284,0.836125585355417
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20622.Liking for broad beans,18192,0.020352687736587,0.0340734443888378,-0.046431263265535,0.087136638738709,0.550302413591524
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20623.Liking for broccoli,18192,-0.0036443317709211,0.0348426774100787,-0.0719359794946754,0.0646473159528332,0.916699203984497
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20624.Liking for brown rice,18192,-0.00907731192910992,0.034292177657213,-0.0762899801372475,0.0581353562790276,0.791239704645791
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20625.Liking for brussel sprouts,18192,-0.0342640068451345,0.0336695662332491,-0.100256356662303,0.0317283429720339,0.308855427899097
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20626.Liking for burgers (meat),18192,-0.0183048244572926,0.0347941020996006,-0.0865012645725097,0.0498916156579246,0.598832191738509
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20627.Liking for burn of spicy foods,18192,-0.065504632027593,0.0352197607178301,-0.13453536303454,0.00352609897935403,0.0629182387984063
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20628.Liking for butter on bread,18192,0.0266678289574362,0.0350233549464739,-0.0419779467376527,0.0953136046525251,0.446410228633802
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20629.Liking for butternut squash,18192,0.00730112004476965,0.0334804134565199,-0.0583204903300093,0.0729227304195486,0.827375943412636
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20630.Liking for cabbage,18192,0.0124083181050592,0.0341836840996629,-0.0545917027302801,0.0794083389403985,0.716616957019482
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20631.Liking for cake,18192,0.00545091049538986,0.0341514551110223,-0.0614859415222138,0.0723877625129935,0.873190150384476
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20632.Liking for cake icing,18192,-0.004217772201389,0.0341816961785976,-0.0712138967114403,0.0627783523086623,0.901797492613389
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20633.Liking for capers,18192,0.0543448084821674,0.0338731541113876,-0.0120465735761523,0.120736190540487,0.108651615908381
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20634.Liking for cauliflower,18192,-0.0402210591158728,0.034609010129501,-0.108054718969695,0.0276126007379491,0.245187482409141
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20635.Liking for cereal or granola bar,18192,0.0274075524933568,0.0336074489463105,-0.0384630474414118,0.0932781524281253,0.414785314027903
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20636.Liking for cheesecake,18192,0.0228906174901833,0.0343077212139054,-0.0443525160890713,0.0901337510694379,0.504643446965928
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20637.Liking for cherries,18192,0.0775665375751241,0.0360846036400077,0.00684071444070891,0.148292360709539,0.0316020636910488
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20638.Liking for chicken,18192,-0.0396202239577861,0.0361241064170943,-0.110423472535291,0.0311830246197187,0.272751790237884
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20639.Liking for chilli pepper,18192,-0.0765059805745699,0.0345802746599208,-0.144283318908015,-0.008728642241125,0.0269502677612506
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20640.Liking for chips or french fries,18192,-0.00840961095632645,0.0343346094462341,-0.0757054454709452,0.0588862235582923,0.806512607702792
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20641.Liking for cigarette smoking,18192,0.0998357171760363,0.0565260450047309,-0.0109553310332363,0.210626765385309,0.0773808222722259
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20642.Liking for cod,18192,-0.0705652065549437,0.034919330504547,-0.139007094343856,-0.00212331876603168,0.0433144489623978
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20643.Liking for coffee with sugar,18192,-0.0427736519129618,0.0382628313240253,-0.117768801308051,0.0322214974821278,0.263628585334889
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20644.Liking for coffee without sugar,18192,0.0192901333921356,0.0347455096891176,-0.0488110655985348,0.0873913323828061,0.57877599422229
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20645.Liking for coriander,18192,-0.0481964849814831,0.0339096343170708,-0.114659368242942,0.0182663982799756,0.155240541764513
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20646.Liking for corn flakes,18192,0.0194117948711116,0.0342452114031243,-0.0477088194790119,0.0865324092212351,0.570825147129079
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20647.Liking for cream,18192,0.00656562867658867,0.0344984005153379,-0.0610512363334737,0.074182493686651,0.849062936808879
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20648.Liking for croissant,18192,0.0120952246794517,0.0345332299766605,-0.0555899060748028,0.0797803554337063,0.726155995880143
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20649.Liking for cucumber,18192,-0.0254868420937562,0.0345977766157343,-0.0932984842605955,0.042324800073083,0.461337875900462
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20650.Liking for curry,18192,-0.0633687075410392,0.0346643600829154,-0.131310853303553,0.00457343822147499,0.0675561679817042
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20651.Liking for dairy products,18192,0.0475494279273128,0.0351449678741202,-0.0213347091059629,0.116433564960589,0.17608804218133
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20652.Liking for dark chocolate,18192,0.0406194779035153,0.0345869115595084,-0.0271708687531212,0.108409824560152,0.24024318864914
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20653.Liking for diet fizzy drinks,18192,0.00202853000288392,0.0353645745685443,-0.0672860361514629,0.0713430961572307,0.954258651089841
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20654.Liking for dried fruit,18192,0.019242079839801,0.0339966000882631,-0.0473912563331946,0.0858754160127967,0.571400686915891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20655.Liking for eggs,18192,0.0559898284998958,0.0350295396069578,-0.0126680691297415,0.124647726129533,0.109980184036555
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20656.Liking for exercising alone,18192,-0.0259532319874362,0.0342149997739928,-0.0930146315444621,0.0411081675695896,0.448141357355515
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20657.Liking for exercising with others,18192,0.00236268687044299,0.0338737738271647,-0.0640299098307998,0.0687552835716858,0.944393620066996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20658.Liking for extra virgin olive oil,18192,-0.0223428581383119,0.0343967562663596,-0.0897605004203767,0.0450747841437529,0.515982789609603
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20659.Liking for fatty foods,18192,0.0218648971172316,0.033887848329047,-0.0445552856077005,0.0882850798421637,0.518796988088315
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20660.Liking for fresh tomatoes,18192,0.0176352176284866,0.0368998999198937,-0.054688586214505,0.0899590214714781,0.632712558790734
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20661.Liking for fried chicken,18192,-0.0496855471959989,0.0343744205094861,-0.117059411394592,0.0176883170025939,0.148356605689385
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20662.Liking for fried or battered fish,18192,0.0015827317994459,0.0345847791638287,-0.0662034353616583,0.0693688989605501,0.963498994582611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20663.Liking for fruit,18192,0.0166038477856712,0.0377393121847319,-0.0573652040964033,0.0905728996677456,0.65997016020921
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20664.Liking for garlic,18192,-0.0150632812333595,0.0341022397150004,-0.0819036710747603,0.0517771086080413,0.658704733973151
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20665.Liking for gherkins,18192,0.03109562369612,0.0338124846042224,-0.0351768461281558,0.0973680935203959,0.357768327586842
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20666.Liking for globe artichoke,18192,0.0280703725570407,0.0345182567829808,-0.0395854107376016,0.095726155851683,0.41611196054116
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20667.Liking for goat's cheese,18192,-0.0363802770724643,0.0344454122057621,-0.103893284995758,0.0311327308508295,0.290903721183521
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20668.Liking for going to a cafe,18192,-0.00220068955175364,0.0345944312269652,-0.0700057747566054,0.0656043956530981,0.949278297459536
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20669.Liking for going to the gym,18192,-0.0196362982124868,0.0337525125882363,-0.0857912228854299,0.0465186264604563,0.560726856526881
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20670.Liking for going to the pub,18192,0.00492085424377899,0.0340812315991649,-0.0618783596905842,0.0717200681781422,0.885197237134471
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20671.Liking for grapefruit,18192,-0.0250720156474493,0.0344226820880812,-0.0925404725400885,0.0423964412451899,0.466404213034271
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20672.Liking for green olives,18192,-0.0214953544786799,0.0338366071934677,-0.0878151045778765,0.0448243956205167,0.525260856110649
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20673.Liking for haddock,18192,-0.0193929115481744,0.0347904065769875,-0.0875821084390699,0.0487962853427211,0.577246524390771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20674.Liking for ham,18192,-0.0121632998400386,0.0344233156030468,-0.0796329984220103,0.0553063987419331,0.72383405678778
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20675.Liking for hard cheese,18192,0.0134376131468208,0.0353347881574142,-0.0558185716417109,0.0826937979353526,0.703731524759087
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20676.Liking for herring,18192,0.0430069008045498,0.0343472018022625,-0.0243136147278847,0.110327416336984,0.210541383912502
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20677.Liking for honey,18192,-0.0414321395431185,0.0341201925416686,-0.108307716924789,0.0254434378385519,0.224649082782502
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20678.Liking for horseradish or wasabi,18192,-0.0132570316355509,0.035147537315355,-0.0821462047736468,0.0556321415025449,0.706042481896956
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20679.Liking for ice cream,18192,-0.02402212153586,0.0350036678842142,-0.0926293105889198,0.0445850675171997,0.492548839987493
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20680.Liking for jam,18192,-0.00529362443310028,0.0349029095361174,-0.0737033271238903,0.0631160782576898,0.879451160449718
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20681.Liking for kiwi fruit,18192,0.0479255961398673,0.0340067754912207,-0.0187276838229253,0.11457887610266,0.158764919637494
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20682.Liking for lager,18192,0.0251575000867639,0.034577163800281,-0.0426137409617868,0.0929287411353146,0.466882807568371
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20683.Liking for lamb,18192,0.0432886978062471,0.0343357178342688,-0.0240093091489197,0.110586704761414,0.207415736321565
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20684.Liking for lemons,18192,0.00445802334701039,0.0340458305464988,-0.0622718045241273,0.0711878512181481,0.895822773903925
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20685.Liking for lentils or beans,18192,-0.0291544318051645,0.0343032276304581,-0.0963887579608624,0.0380798943505333,0.395389961500309
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20686.Liking for liver,18192,0.021812854236731,0.0342405791307368,-0.0452986808595132,0.0889243893329752,0.524102331726543
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20687.Liking for mackerel,18192,0.0165158274612301,0.03417375555432,-0.0504647334252371,0.0834963883476974,0.628895805638384
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20688.Liking for marzipan,18192,0.0500954318108412,0.0340766625339653,-0.0166948267557308,0.116885690377413,0.14155731080361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20689.Liking for mayonnaise,18192,-0.00746173841132454,0.0343978912303433,-0.0748816052227973,0.0599581284001482,0.828269776890622
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20690.Liking for melon,18192,0.0207208865380042,0.0355132849961608,-0.0488851520544711,0.0903269251304794,0.559585134145422
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20691.Liking for milk chocolate,18192,-0.0506726643743968,0.0345346617791972,-0.118360601461623,0.0170152727128298,0.142312125858394
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20692.Liking for mushrooms,18192,0.0209937295766605,0.0347653095620506,-0.0471462771649586,0.0891337363182796,0.545937574833699
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20694.Liking for orange juice,18192,0.0126366943046752,0.0347185055604195,-0.0554115765937471,0.0806849652030975,0.71588034875471
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20695.Liking for oranges,18192,-0.0823192103464163,0.0348628812987473,-0.150650457691961,-0.0139879630008715,0.018225024503423
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20696.Liking for pasta,18192,0.00998898416758016,0.0339821957728461,-0.0566161195471982,0.0765940878823585,0.768801318384012
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20697.Liking for pears,18192,-0.0177915173010843,0.0346820853185098,-0.0857684045253634,0.0501853699231949,0.607965473332381
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20698.Liking for pizza,18192,0.0578977413892004,0.0346150979990664,-0.00994785068896967,0.12574333346737,0.0944202764074468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20699.Liking for plain yogurt,18192,-0.00181958422939669,0.0335930476313202,-0.0676619575867842,0.0640227891279908,0.956803902669314
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20700.Liking for plums,18192,0.0413066973908096,0.0351187298355885,-0.0275260130869438,0.110139407868563,0.239529836305672
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20701.Liking for pollock,18192,-0.0358090511941125,0.0344533196656184,-0.103337557738725,0.0317194553504995,0.298655908692627
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20702.Liking for pork chop,18192,0.0523444271164902,0.0347697169226863,-0.0158042180519749,0.120493072284955,0.132223169805425
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20703.Liking for porridge,18192,-0.0765868650757268,0.0348770739781696,-0.144945930072939,-0.00822780007851444,0.0281110836923603
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20704.Liking for potato crisps,18192,-0.0159393645550242,0.0348384696787239,-0.0842227651253231,0.0523440360152747,0.647301400313885
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20705.Liking for potatoes,18192,-0.0273852792675522,0.0343701142066519,-0.0947507031125899,0.0399801445774855,0.425591594835997
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20706.Liking for prawns,18192,0.00673965420298116,0.0345823990513134,-0.0610418479375931,0.0745211563435554,0.845483721945981
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20707.Liking for raw carrots,18192,0.0337997487968738,0.0340570525036492,-0.0329520741102786,0.100551571704026,0.32099375149448
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20708.Liking for red meat,18192,0.0298751268577598,0.0347170068935321,-0.0381702066535632,0.0979204603690827,0.389506707169896
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20709.Liking for red wine,18192,0.0601689457059714,0.0341239648794358,-0.00671402545772274,0.127051916869666,0.0778758097203457
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18192,0.0187542183541849,0.0352576274461703,-0.0503507314403088,0.0878591681486787,0.594788278349673
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20711.Liking for roast chicken,18192,-0.0175212808884803,0.0364375756930741,-0.0889389292469056,0.0538963674699449,0.630623583408168
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20712.Liking for salad dressing,18192,-0.0184979513055367,0.0348922254341139,-0.0868867131563998,0.0498908105453265,0.596017632132835
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20713.Liking for salad leaves,18192,0.05226913284182,0.0362777963914517,-0.0188353480854254,0.123373613769065,0.14965777298917
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20714.Liking for salami,18192,-0.0105321127377548,0.0336738418985978,-0.0765328428590065,0.055468617383497,0.754460235213186
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20715.Liking for salmon,18192,0.00350209551505867,0.0350695220296394,-0.0652341676630346,0.072238358693152,0.920455373844543
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20716.Liking for salty foods,18192,-0.0310407322178769,0.0339455309195036,-0.097573972820104,0.0354925083843501,0.36050431097402
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20717.Liking for salty pretzels,18192,0.0339595862127518,0.0335439516508035,-0.0317865590228231,0.0997057314483266,0.311364743142645
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20718.Liking for sardines,18192,0.0435309293320192,0.0343996345228985,-0.0238923543328618,0.1109542129969,0.205727207254239
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20719.Liking for sausages (meat),18192,0.00523091828343141,0.0341189239537968,-0.0616421726660104,0.0721040092328732,0.878152142068584
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20720.Liking for savoury biscuits,18192,0.030068104905366,0.0340413452110263,-0.0366529317082455,0.0967891415189776,0.377095654258587
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18192,0.0686903714514291,0.0345493497465666,0.000973645948158477,0.1364070969547,0.0468066214549831
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20722.Liking for skimmed milk,18192,-0.0467205023489878,0.03490535390692,-0.115134996006551,0.0216939913085754,0.180753177896687
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20723.Liking for smoked fish,18192,0.0462392454685794,0.0345855686366757,-0.021548469059305,0.114026959996464,0.18125504138633
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20724.Liking for soft cheese,18192,0.0262021040040679,0.0349037006710623,-0.0422091493112142,0.0946133573193499,0.452844740003413
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20725.Liking for soy sauce,18192,-0.0243667439194279,0.0344093553767544,-0.0918090804578666,0.0430755926190107,0.478865547211724
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20726.Liking for soya milk,18192,-0.0209486907584971,0.0345710088896761,-0.0887078681822624,0.0468104866652681,0.544548074203232
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20727.Liking for spicy foods,18192,-0.0679525758805038,0.0345073565141406,-0.135586994648219,-0.000318157112788223,0.0489430067515876
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20728.Liking for spinach,18192,0.00717260479674662,0.0343780170474306,-0.0602083086162173,0.0745535182097105,0.83473218148378
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20729.Liking for spirits,18192,0.0446416012090623,0.0344909280335922,-0.0229606177367785,0.112243820154903,0.195578336098329
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20730.Liking for strawberries,18192,0.00215289724112851,0.0378690690490592,-0.0720704780950275,0.0763762725772845,0.954664453796006
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18192,-0.0450163169569706,0.0357440890521419,-0.115074731499169,0.0250420975852275,0.207899934731622
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20732.Liking for sweet foods,18192,-0.0338532770317314,0.033885317239515,-0.100268498821181,0.032561944757718,0.317781619263924
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20733.Liking for taking the stairs,18192,-0.0641044974945796,0.0352455047447161,-0.133185686794223,0.00497669180506402,0.0689585178480397
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20734.Liking for tea with sugar,18192,-0.0477847284244414,0.0428762030269284,-0.131822086357221,0.0362526295083382,0.265087484956871
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20735.Liking for tea without sugar,18192,-0.000649458775560487,0.0361077690470051,-0.0714206861076906,0.0701217685565696,0.985649679483883
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20736.Liking for tomato ketchup,18192,-0.0371634589530553,0.0351373604278842,-0.106032685391708,0.0317057674855977,0.290223522678524
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20737.Liking for tinned tuna,18192,-0.00261964061021436,0.0337698534829634,-0.0688085534368226,0.0635692722163939,0.938168297557668
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20738.Liking for turnip (white),18192,-0.00954505710149791,0.0341913267023861,-0.0765600574381747,0.0574699432351789,0.780120585527653
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20739.Liking for vegetables,18192,0.021972205161998,0.0379956203793926,-0.0524992107816116,0.0964436211056075,0.563080524648785
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20740.Liking for vinegar,18192,-0.0171114177311498,0.0342470931086597,-0.0842357202241229,0.0500128847618233,0.617330522230222
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20741.Liking for watching television,18192,0.0221148372853397,0.0342027392804508,-0.0449225317043439,0.0891522062750234,0.517911402750601
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20742.Liking for whisky,18192,0.0875015471931075,0.0357578769801899,0.0174161083119354,0.15758698607428,0.0144122276502573
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20743.Liking for white bread,18192,0.0164564696500687,0.0341870932504877,-0.0505502331208872,0.0834631724210246,0.630262914803181
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20744.Liking for white rice,18192,-0.000309443974350104,0.0339194026874734,-0.0667914732417979,0.0661725852930977,0.992721164648354
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20745.Liking for white wine,18192,0.0469221158888913,0.0341393169480131,-0.0199909453292145,0.113835177106997,0.169325048097935
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18192,0.0235587318110794,0.0358773630389024,-0.0467608997451694,0.0938783633673281,0.511416792736618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20747.Liking for whole milk,18192,0.00642708941384083,0.0344509064779818,-0.0610966872830036,0.0739508661106852,0.852009346173543
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20748.Liking for wholemeal bread,18192,0.010899014173649,0.0350326469911017,-0.0577649739289102,0.0795630022762083,0.755720408503979
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20749.Liking for working up a sweat,18192,-0.0524726608935275,0.0346030705641543,-0.12029467919927,0.0153493574122149,0.129431512389859
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21001.Body mass index (BMI),50058,-0.0240146458895887,0.00759078721868007,-0.0388925888382017,-0.00913670294097578,0.00155893525702876
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21002.Weight,50098,-0.0016451235953447,0.00427847878642504,-0.0100309420167378,0.00674069482604837,0.700601127941201
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21021.Pulse wave Arterial Stiffness index,16673,0.00313155958654987,0.00328373565939986,-0.00330456230587386,0.00956768147897359,0.340270807766996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17396,0.0702738915880728,0.0356758059443016,0.000349311937241734,0.140198471238904,0.0488781526980333
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17413,-0.053593146271445,0.0374564926530764,-0.127007871871475,0.0198215793285848,0.152502470128457
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17415,-0.00855920828252416,0.0370662353789186,-0.0812090296252046,0.0640906130601562,0.817382325623199
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21040.Satisfaction with bowel habits,17341,-0.00905957254590874,0.0338265204520986,-0.075359552632022,0.0572404075402045,0.788837563936479
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17319,0.00732893047205684,0.0367244118231774,-0.0646509167013708,0.0793087776454845,0.841822654385371
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21042.Greatest number of times bowels opened per day,17329,0.0179824735097167,0.0371919610990587,-0.0549137702444383,0.0908787172638716,0.628743814214775
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21043.Least number of times bowels opened per week,17209,-0.0385461346039021,0.0369812341766856,-0.111029353590206,0.0339370843824016,0.297279820061778
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21044.Average number of times bowels opened per day,17266,0.014142864900935,0.0415934317046763,-0.0673802612402305,0.0956659910421006,0.733840787391968
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17424,-0.0250717178529617,0.0380379134422296,-0.0996260281997316,0.0494825924938083,0.509824589795786
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17414,-0.0441865020666057,0.0385938960679142,-0.119830538359717,0.031457534226506,0.252262570705939
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,9798,0.142853340721283,0.0630403035310638,0.0192943458003975,0.266412335642168,0.023469237848099
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17419,0.0540883265534124,0.0425087401257903,-0.0292288040931366,0.137405457199961,0.203246315327114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17416,0.0099937580989214,0.0576148873807668,-0.102931421167382,0.122918937365224,0.862293524865622
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17417,0.046723745075663,0.0456383857391248,-0.0427274909730215,0.136174981124348,0.305952617335428
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17416,0.000215675880900988,0.110522766114294,-0.216408945703115,0.216840297464917,0.99844301875515
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17423,0.00416163335466789,0.0435169427979584,-0.0811315745293307,0.0894548412386664,0.923813565367309
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17420,-0.0300259139879523,0.0427564909981996,-0.113828636344424,0.0537768083685189,0.482530207283545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17023,-0.0581141821304659,0.0393104151314618,-0.135162595788131,0.0189342315271991,0.139335158908205
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17413,-0.0453365547450143,0.0384137224845041,-0.120627450814642,0.0299543413246137,0.237929781726989
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17420,-0.0862937131711582,0.0529503264317603,-0.190076352977408,0.0174889266350919,0.103180752328224
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17423,-0.0080611720391438,0.0376864442364938,-0.0819266027426716,0.065804258664384,0.830626684218685
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17420,0.0606250901225211,0.0379952795798666,-0.0138456578540175,0.13509583809906,0.110597329769818
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X21100.Water hardness (USGS classification),49791,-0.0163478326136948,0.022021533837135,-0.0595100389344794,0.0268143737070898,0.457874765680198
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2139.Age first had sexual intercourse,43426,0.00340661908188049,0.00197682628650559,-0.000467960439670466,0.00728119860343144,0.084845583102559
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2149.Lifetime number of sexual partners,40274,0.0133183572011079,0.0246915131257774,-0.0350770085254159,0.0617137229276316,0.589620708526613
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22032.IPAQ activity group,40276,0.0241893383502536,0.0245264993259425,-0.0238826003285937,0.0722612770291009,0.324014807764542
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22033.Summed days activity,41337,0.00168211724795499,0.00188843656618282,-0.00201921842176334,0.00538345291767332,0.373070656564462
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22034.Summed minutes activity,40276,0.00158123987141997,0.00191197357686456,-0.00216622833923457,0.00532870808207451,0.408230779939956
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22037.MET minutes per week for walking,38556,0.00222369943802763,0.00193944628828634,-0.00157761528701359,0.00602501416306885,0.251568949467375
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22038.MET minutes per week for moderate activity,40276,0.00054408615972595,0.00191675684311724,-0.00321275725278384,0.00430092957223574,0.776520905428921
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22039.MET minutes per week for vigorous activity,40276,0.0298774338150263,0.0244089506849886,-0.0179641095275513,0.0777189771576039,0.220945818473044
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22040.Summed MET minutes per week for all activity,38556,0.00266053952514432,0.00194842406275022,-0.00115837163784611,0.00647945068813475,0.172109327621242
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X2217.Age started wearing glasses or contact lenses,42749,-0.00176880706736397,0.00190015774948309,-0.00549311625635082,0.00195550212162289,0.351924106416643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X22501.Year ended full time education,12221,0.00294082790708939,0.00893861278083917,-0.0145788531433554,0.0204605089575342,0.742159277155435
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X22506.Tobacco smoking,12141,0.135712232058951,0.0874895846136426,-0.0357673537837883,0.307191817901691,0.120884274522234
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46990,-0.0296966159079075,0.0592948450357602,-0.145914512177998,0.0865212803621825,0.61649337010307
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23098.Weight,49249,-0.000917652025607585,0.00431267845043083,-0.00937050178845202,0.00753519773723685,0.83149938998101
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23099.Body fat percentage,49221,1.41194743286259e-05,0.0041395405026656,-0.00809937991089595,0.0081276188595532,0.997278530917782
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23100.Whole body fat mass,49172,-0.00125748490785437,0.00399560946430616,-0.00908887945789445,0.00657390964218571,0.752978121349186
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23101.Whole body fat-free mass,49243,-0.000184846665769036,0.00360695536294703,-0.00725447917714522,0.00688478584560715,0.959128682076519
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23102.Whole body water mass,49249,-5.59934791967256e-05,0.00361133178452243,-0.00713420377686068,0.00702221681846723,0.987629407002021
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23104.Body mass index (BMI),49249,-0.0236876050290701,0.00762602839996153,-0.0386346206929947,-0.00874058936514554,0.00189646790096546
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23105.Basal metabolic rate,49247,-0.000286400915428739,0.00385927205725106,-0.00785057414764081,0.00727777231678333,0.940842696446857
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23106.Impedance of whole body,49244,0.00295070407924314,0.00295157522754542,-0.00283438336674589,0.00873579152523217,0.317458276395055
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23107.Impedance of leg (right),49246,0.00317463486507171,0.00240930922082078,-0.00154761120773701,0.00789688093788044,0.187625779731617
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23108.Impedance of leg (left),49245,0.0020265194358857,0.00239308319019839,-0.00266392361690314,0.00671696248867454,0.397097541695183
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23109.Impedance of arm (right),49236,0.00304726177724238,0.00294162143015958,-0.00271831622587039,0.00881283978035516,0.300248154905415
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23110.Impedance of arm (left),49244,0.00273739337958288,0.00294525024964337,-0.00303529710971813,0.0085100838688839,0.352672701037255
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23111.Leg fat percentage (right),49245,0.00484425044670153,0.00500538453970143,-0.00496630325111327,0.0146548041445163,0.333145097240308
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23112.Leg fat mass (right),49244,0.00163997254978678,0.00532280682124542,-0.00879272881985425,0.0120726739194278,0.758005290677307
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23113.Leg fat-free mass (right),49243,-0.000981015019319019,0.00377356593048765,-0.00837720424307481,0.00641517420443678,0.794887780224187
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23114.Leg predicted mass (right),49242,-0.000824615253413144,0.00379224800195586,-0.00825742133724662,0.00660819083042033,0.827860434757728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23115.Leg fat percentage (left),49239,0.0032273342084411,0.00521587727715431,-0.00699578525478136,0.0134504536716636,0.536082647489393
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23116.Leg fat mass (left),49239,-0.000784955152655043,0.0055514306594529,-0.0116657592451827,0.0100958489398726,0.887556972211585
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23117.Leg fat-free mass (left),49236,0.000109585739777089,0.00394196880536798,-0.00761667311874416,0.00783584459829833,0.977821979580457
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23118.Leg predicted mass (left),49235,6.91102882924753e-05,0.00396192499347754,-0.0076962626989235,0.00783448327550846,0.986082786602231
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23119.Arm fat percentage (right),49235,-0.00291862390692652,0.00459138467472821,-0.0119177378693938,0.00608049005554077,0.524991875151647
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23120.Arm fat mass (right),49230,-0.00825779852756364,0.00454957923487933,-0.0171749738279271,0.000659376772799843,0.0695194480657876
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23121.Arm fat-free mass (right),49231,-0.00131086524399276,0.00363152000089861,-0.00842864444575404,0.00580691395776852,0.718124355695788
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23122.Arm predicted mass (right),49230,-0.00219189223927409,0.0036365990245839,-0.00931962632745852,0.00493584184891035,0.546690199647449
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23123.Arm fat percentage (left),49225,-0.00270233854036135,0.0047128703164144,-0.0119395643605336,0.00653488727981087,0.56637956977862
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23124.Arm fat mass (left),49224,-0.00695144567547186,0.00454015428850427,-0.0158501480809402,0.00194725672999651,0.125750267284245
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23125.Arm fat-free mass (left),49220,-0.000490778176522294,0.00370175522430971,-0.00774621841616933,0.00676466206312474,0.89452620604612
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23126.Arm predicted mass (left),49217,-0.000739825646837159,0.00371307240726756,-0.00801744756508157,0.00653779627140725,0.842068861458619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23127.Trunk fat percentage,49213,-0.000458012359842564,0.00296837702904514,-0.00627603133677105,0.00536000661708592,0.877376012424433
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23128.Trunk fat mass,49209,0.000119313990553889,0.00326616340076755,-0.00628236627495051,0.00652099425605829,0.970859652082279
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23129.Trunk fat-free mass,49202,0.000106195968144292,0.00327193973892396,-0.00630680592014668,0.00651919785643526,0.974108075001572
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23130.Trunk predicted mass,49197,4.79699951125106e-05,0.00327336155648797,-0.00636781865560392,0.00646375864582894,0.98830775234343
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23400.Total Cholesterol,28797,0.00777406605319022,0.00241103550189914,0.00304843646946791,0.0124996956369125,0.00126391757894147
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,28797,0.00728195531604215,0.00233704205638674,0.00270135288552415,0.0118625577465602,0.00183573787317406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",28797,0.00728625838376136,0.00234144340019807,0.00269702931937313,0.0118754874481496,0.00186090682566337
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23403.VLDL Cholesterol,28797,0.00603481635310919,0.0023480289663649,0.00143267957903399,0.0106369531271844,0.0101700604089397
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23404.Clinical LDL Cholesterol,28797,0.00705781498307386,0.00234006933882243,0.0024712790789819,0.0116443508871658,0.00256296827398019
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23405.LDL Cholesterol,28797,0.00708861453808103,0.00233337797542605,0.00251519370624597,0.0116620353699161,0.00238430962450556
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23406.HDL Cholesterol,28797,0.00355045515417401,0.00271489622022148,-0.0017707414374601,0.00887165174580812,0.190962361715167
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23407.Total Triglycerides,28797,0.00314516872928194,0.00249019266662025,-0.00173560889729374,0.00802594635585762,0.206591417076625
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23408.Triglycerides in VLDL,28797,0.00287209000676098,0.00250846082840023,-0.00204449321690347,0.00778867323042543,0.252234802449753
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23409.Triglycerides in LDL,28797,0.00399744932879031,0.0024140891193562,-0.000734165345147847,0.00872906400272846,0.0977563994683804
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23410.Triglycerides in HDL,28797,0.0024712548786838,0.00240166042351463,-0.00223599955140487,0.00717850930877247,0.303498827999627
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,28797,0.00703604092357144,0.00244723506798456,0.0022394601903217,0.0118326216568212,0.00404198041111713
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23412.Phospholipids in VLDL,28797,0.00489763142152307,0.00240402502023484,0.000185742381862778,0.00960952046118336,0.0416328135827102
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23413.Phospholipids in LDL,28797,0.00716099256954645,0.00232834182514795,0.00259744259225648,0.0117245425468364,0.00210293177028388
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23414.Phospholipids in HDL,28797,0.00284482807500464,0.00261820643521719,-0.00228685653802105,0.00797651268803033,0.27724215103997
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23415.Total Esterified Cholesterol,28797,0.00764674702348128,0.00242304223729601,0.0028975842383811,0.0123959098085815,0.00160198450407149
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,28797,0.00648762325460725,0.00233417865911108,0.00191263308274954,0.011062613426465,0.00544942317702011
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23417.Cholesteryl Esters in LDL,28797,0.00701267330398967,0.0023286713818541,0.00244847739555564,0.0115768692124237,0.00260230332099515
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23418.Cholesteryl Esters in HDL,28797,0.0031281280484459,0.00270620525583332,-0.00217603425298741,0.00843229034987921,0.24772781867288
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23419.Total Free Cholesterol,28797,0.007935269028276,0.00238273619626956,0.00326510608358766,0.0126054319729643,0.000868558922451012
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23420.Free Cholesterol in VLDL,28797,0.00533099736127574,0.00238039921465526,0.000665414900551426,0.00999657982200006,0.025128458225555
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23421.Free Cholesterol in LDL,28797,0.00702252732437411,0.0023566841355589,0.00240342641867866,0.0116416282300696,0.00288645484140906
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23422.Free Cholesterol in HDL,28797,0.00465587112710721,0.00271343901710315,-0.000662469346414952,0.00997421160062938,0.0861991285331733
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,28797,0.00690874941661449,0.00236324185596456,0.00227679537892396,0.011540703454305,0.00346478359415666
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23424.Total Lipids in VLDL,28797,0.00435071776800665,0.00243540922112635,-0.00042268430540099,0.00912411984141429,0.0740382124269451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23425.Total Lipids in LDL,28797,0.00710459107715705,0.00233016194119738,0.00253747367241018,0.0116717084819039,0.00229836787844773
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23426.Total Lipids in HDL,28797,0.00333544679730211,0.00265517793787418,-0.00186870196093128,0.0085395955555355,0.209051987319227
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,28797,0.00505014713370732,0.00248997016093757,0.000169805618269679,0.00993048864914496,0.0425494542568996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23428.Concentration of VLDL Particles,28797,0.00595696239255314,0.00236932727622759,0.00131308093114706,0.0106008438539592,0.0119356882862335
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23429.Concentration of LDL Particles,28797,0.00707527169934095,0.00232435614539894,0.00251953365435903,0.0116310097443229,0.00233688672024652
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23430.Concentration of HDL Particles,28797,0.00395172762131046,0.00249917362825786,-0.000946652690074945,0.00885010793269586,0.113840167905465
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23431.Average Diameter for VLDL Particles,28797,-0.000449756524623636,0.00260521544386902,-0.00555597879460692,0.00465646574535965,0.862937996853533
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23432.Average Diameter for LDL Particles,28797,0.00402740368311438,0.00243717504945873,-0.000749459413824721,0.00880426678005349,0.0984459194665232
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23433.Average Diameter for HDL Particles,28797,0.00183040280568732,0.00278337900945873,-0.00362502005285178,0.00728582566422643,0.510788267956133
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23434.Phosphoglycerides,28774,0.00593216809205239,0.00246433226286804,0.00110207685683103,0.0107622593272738,0.0160811319805711
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,28774,0.000495630299222469,0.00264459677079099,-0.00468777937152788,0.00567903996997281,0.85133860196293
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23436.Total Cholines,28774,0.0066108778160882,0.00248581650971126,0.00173867745705413,0.0114830781751223,0.0078314226673495
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23437.Phosphatidylcholines,28774,0.00644623995290673,0.00249640341136091,0.00155328926663934,0.0113391906391741,0.00982185564992356
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23438.Sphingomyelins,28773,0.00812795798787458,0.00250178431904941,0.00322446072253773,0.0130314552532114,0.00115999667898821
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23439.Apolipoprotein B,28797,0.00714258637842687,0.00232718441535051,0.00258130492433987,0.0117038678325139,0.00214834959847715
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23440.Apolipoprotein A1,28797,0.00328178170576814,0.00258432804707136,-0.00178350126649173,0.00834706467802801,0.204138305354302
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,28797,0.00497335078972698,0.00237643025709129,0.000315547485828046,0.00963115409362591,0.0363773407699491
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23442.Total Fatty Acids,28774,0.00483658562503151,0.00237163634618247,0.000188178386513874,0.00948499286354914,0.0414246907351664
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23443.Degree of Unsaturation,28774,0.0028082742416737,0.00256918946930229,-0.00222733711815878,0.00784388560150618,0.274377295822415
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23444.Omega-3 Fatty Acids,28774,0.00450432004872468,0.00242105736897211,-0.000240952394460649,0.00924959249191,0.0628283562869421
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23445.Omega-6 Fatty Acids,28774,0.00593516620023379,0.00237161060326253,0.00128680941783923,0.0105835229826283,0.0123343719148126
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,28774,0.00619724635318447,0.00238396816446058,0.00152466875084174,0.0108698239555272,0.00933935431288546
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23447.Monounsaturated Fatty Acids,28774,0.0034581271952955,0.00243255116200841,-0.00130967308224099,0.00822592747283199,0.155151759965611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23448.Saturated Fatty Acids,28774,0.00434252560685725,0.00238390096899767,-0.000329920292378182,0.00901497150609268,0.0685253445864085
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23449.Linoleic Acid,28774,0.00570426339692513,0.00236336635540803,0.00107206534032539,0.0103364614535249,0.015801223364503
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23450.Docosahexaenoic Acid,28774,0.00462044151176413,0.00249026467105824,-0.000260477243510015,0.00950136026703828,0.0635490970921431
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,28774,0.00270857058611711,0.00244250576955438,-0.00207874072220948,0.0074958818944437,0.267469183210098
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,28774,-0.00100687427560062,0.00254279106364321,-0.00599074476034132,0.00397699620914008,0.692128560052177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,28774,0.00023944312858938,0.00259153085861382,-0.00483995735429371,0.00531884361147247,0.926385273892525
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,28774,-0.000616643800017037,0.00263713267117315,-0.0057854238355164,0.00455213623548233,0.815117719728467
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,28774,0.000122220523360078,0.00238361858423383,-0.00454967190173823,0.00479411294845838,0.95910658448396
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,28774,0.00178940436419988,0.0025375838938328,-0.00318426006771242,0.00676306879611217,0.480715963403364
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,28774,0.00161796814940752,0.00250245477516243,-0.00328684320991083,0.00652277950872588,0.517926830530945
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,28774,0.000462103061783559,0.00263822726981701,-0.00470882238705777,0.00563302851062489,0.860957775652036
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,28772,-0.00249475649462089,0.00241676806778062,-0.00723162190747091,0.00224210891822913,0.301954463198991
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23460.Alanine,28788,0.00196083653928541,0.00236973669589106,-0.00268384738466107,0.00660552046323189,0.407989412512142
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23461.Glutamine,28714,0.00538919901398399,0.00235929885906606,0.000764973250214517,0.0100134247777535,0.022364841973068
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23462.Glycine,28762,0.000975752431611747,0.00248555156781829,-0.0038959286413121,0.00584743350453559,0.694640173984189
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23463.Histidine,28760,0.00392392571500941,0.00233812872766837,-0.000658806591220607,0.00850665802123942,0.0933124145476621
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),28776,0.00389965665640242,0.00247867975374626,-0.000958555660940254,0.00875786897374509,0.115665055953864
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23465.Isoleucine,28791,0.00501141551145006,0.00241692766095835,0.000274237295971694,0.00974859372692843,0.0381378774264723
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23466.Leucine,28792,0.00416265854491938,0.00246911316568678,-0.000676803259826708,0.00900212034966546,0.091827411469624
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23467.Valine,28776,0.00287108419232526,0.00248447221262262,-0.00199848134441508,0.0077406497290656,0.247849778631866
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23468.Phenylalanine,28786,0.00217743835580764,0.00236221901285135,-0.00245251090938101,0.00680738762099629,0.356652812359409
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23469.Tyrosine,28764,0.000435847500248423,0.00240523592921954,-0.00427841492102188,0.00515010992151873,0.856205753395147
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23470.Glucose,28742,0.00197576555814837,0.00237715054046721,-0.00268344950116737,0.0066349806174641,0.405896544293203
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23471.Lactate,28744,0.000104898800888468,0.00236094179952928,-0.00452254712618892,0.00473234472796586,0.964561229342597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23472.Pyruvate,28713,0.00400245836166582,0.00235780878865962,-0.00061884686410703,0.00862376358743867,0.0896067687580219
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23473.Citrate,28793,-0.000236609798991249,0.00238376153986955,-0.00490878241713557,0.00443556281915307,0.920933318104038
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23474.3-Hydroxybutyrate,28331,0.000703989231833915,0.00240189608282504,-0.00400372709050317,0.005411705554171,0.769449936149358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23475.Acetate,28772,0.00247565291679786,0.00235193829313849,-0.00213414613775358,0.0070854519713493,0.292532680867663
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23476.Acetoacetate,28795,0.00125462471397008,0.00235056369590346,-0.0033524801300007,0.00586172955794085,0.593515294478641
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23477.Acetone,28795,0.00134594283850653,0.00235276645986348,-0.0032654794228259,0.00595736509983896,0.567280249919614
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23478.Creatinine,28077,0.000555420786036022,0.00280547445130443,-0.00494330913852066,0.0060541507105927,0.843064110650024
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23479.Albumin,28794,0.00593726911154577,0.00238396977055516,0.00126468836125766,0.0106098498618339,0.0127620581109096
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23480.Glycoprotein Acetyls,28797,0.00353189865864918,0.00250216887277309,-0.00137235233198607,0.00843614964928443,0.15809776562223
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,28797,0.000493108567233092,0.0025164312000616,-0.00443909658488764,0.00542531371935382,0.844646369522703
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,28797,-0.000255350199077711,0.00251050203717157,-0.00517593419193399,0.00466523379377857,0.918985348050617
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,28797,0.000287849236271278,0.00252627629223257,-0.00466365229650455,0.00523935076904711,0.909284483355861
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,28797,0.000370260220049837,0.00250305263759587,-0.00453572294963808,0.00527624338973775,0.882404205437145
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,28797,0.00114952234861521,0.00249373029468845,-0.00373818902897414,0.00603723372620457,0.644827209551649
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,28797,-6.46610487786789e-05,0.00250388044308609,-0.00497226671722741,0.00484294461967005,0.979397630371133
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,28797,7.43877294875831e-05,0.00249830351806798,-0.00482228716592566,0.00497106262490082,0.976246466529253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,28797,0.00238267834601331,0.00252915172731487,-0.00257445903952382,0.00733981573155045,0.346156536207344
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,28797,0.00227810614122576,0.00252550698206961,-0.00267188754363067,0.00722809982608219,0.367043625596326
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,28797,0.00244866470201697,0.00251009323174094,-0.00247111803219527,0.00736844743622922,0.329306919921742
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,28797,0.00374309181606157,0.00245624849577281,-0.00107115523565314,0.00855733886777629,0.127543181322874
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,28797,0.00457968005047726,0.00242215664159277,-0.000167746967044559,0.00932710706799909,0.0586684544858942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,28797,0.0028226461857116,0.00248882251138252,-0.00205544593659814,0.00770073830802134,0.256749818714527
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,28797,0.00183179645995291,0.00254918959576628,-0.00316461514774899,0.00682820806765481,0.472405621239897
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23495.Concentration of Large VLDL Particles,28797,0.00332811511644277,0.00249758451522171,-0.00156715053339178,0.00822338076627732,0.182695479058178
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23496.Total Lipids in Large VLDL,28797,0.00356721164199348,0.00249231773066114,-0.00131773111010235,0.0084521543940893,0.1523600223404
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23497.Phospholipids in Large VLDL,28797,0.00306035254229307,0.00250670734171125,-0.00185279384746098,0.00797349893204712,0.222146945153114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23498.Cholesterol in Large VLDL,28797,0.0043507473325309,0.00244466028852054,-0.000440786832969351,0.00914228149803116,0.0751365953211252
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,28797,0.00501104144657622,0.00239985410437548,0.000307327402000283,0.00971475549115216,0.0368011123154608
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,28797,0.0034811201658673,0.00249404711236905,-0.00140721217437604,0.00836945250611065,0.162794046959033
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23501.Triglycerides in Large VLDL,28797,0.00341190463100099,0.00250238661284006,-0.00149277313016553,0.00831658239216751,0.172748173581323
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,28797,0.00631826371480606,0.00234602233974087,0.00172005992891396,0.0109164675006982,0.00708147415790962
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23503.Total Lipids in Medium VLDL,28797,0.00611287227048344,0.00236663981805765,0.00147425822709044,0.0107514863138764,0.00980131972884612
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23504.Phospholipids in Medium VLDL,28797,0.00646901951919249,0.00234035722612495,0.00188191935598758,0.0110561196823974,0.00571134871218164
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23505.Cholesterol in Medium VLDL,28797,0.00721111326501605,0.00233294277634975,0.00263854542337053,0.0117836811066616,0.00199677753406033
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,28797,0.00728271226210498,0.00235661228250065,0.00266375218840371,0.0119016723358062,0.00200124163411537
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,28797,0.00678673967828023,0.00233064350912148,0.00221867840040214,0.0113548009561583,0.00359444856075521
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23508.Triglycerides in Medium VLDL,28797,0.00435805742260304,0.00245791840514497,-0.000459462651481097,0.00917557749668717,0.0762279487181757
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23509.Concentration of Small VLDL Particles,28797,0.00560490702642466,0.00239948724654005,0.000901912023206163,0.0103079020296432,0.0195044833057814
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23510.Total Lipids in Small VLDL,28797,0.0057605741953494,0.00239027010644482,0.00107564478671756,0.0104455036039812,0.0159583270033125
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23511.Phospholipids in Small VLDL,28797,0.00657719728923524,0.00234761925616122,0.00197586354715925,0.0111785310313112,0.00508766226534919
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23512.Cholesterol in Small VLDL,28797,0.00662557365659937,0.00234042814853911,0.00203833448546272,0.011212812827736,0.00464459507452056
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,28797,0.00628600466768272,0.00235115567590931,0.00167773954290047,0.010894269792465,0.00750885373884597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,28797,0.00704855586571688,0.00232920906997864,0.00248330608855874,0.011613805642875,0.00247901180043755
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23515.Triglycerides in Small VLDL,28797,0.00365152030585848,0.00246730401043967,-0.00118439555460328,0.00848743616632024,0.138893886283571
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,28797,0.00692315881157509,0.00236321622123559,0.00229125501795332,0.0115550626051968,0.00339720153432453
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,28797,0.00698062131271219,0.00237142171679934,0.00233263474778547,0.0116286078776389,0.00324631900805252
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,28797,0.00657154241899139,0.00236877428922375,0.00192874481211283,0.0112143400258699,0.00553669191997058
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,28797,0.00744087152354817,0.00239986165346433,0.00273714268275809,0.0121446003643383,0.00193353387541483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,28797,0.00749651299011952,0.00241824652460044,0.00275674980190266,0.0122362761783364,0.00193721198322388
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,28797,0.00705323440276565,0.00237078945669504,0.00240648706764337,0.0116999817378879,0.00293176992506918
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,28797,0.00405586966937865,0.00242914535520306,-0.000705255226819355,0.00881699456557665,0.0949956652644881
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23523.Concentration of IDL Particles,28797,0.00710788024976856,0.00235435456956972,0.0024933452934119,0.0117224152061252,0.0025380278900395
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23524.Total Lipids in IDL,28797,0.00795658120991603,0.0024136440132063,0.00322583894403168,0.0126873234758004,0.000980155370325298
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23525.Phospholipids in IDL,28797,0.00797383580131379,0.00241669001458244,0.00323712337273221,0.0127105482298954,0.000969795261439736
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23526.Cholesterol in IDL,28797,0.00779002891366683,0.0024236881310526,0.00303960017680374,0.0125404576505299,0.00130988339084917
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23527.Cholesteryl Esters in IDL,28797,0.00795730536200933,0.00242285012073469,0.00320851912536933,0.0127060915986493,0.00102367241020176
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23528.Free Cholesterol in IDL,28797,0.00720640029140961,0.00242210935599503,0.00245906595365936,0.0119537346291599,0.00292985241461756
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23529.Triglycerides in IDL,28797,0.00442994881424113,0.00240570908841058,-0.000285240999043605,0.00914513862752587,0.0655686141530445
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23530.Concentration of Large LDL Particles,28797,0.00717917431102214,0.00232899995454201,0.0026143344001198,0.0117440142219245,0.00205454232678585
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23531.Total Lipids in Large LDL,28797,0.00722713624910527,0.00234744905732494,0.00262613609674839,0.0118281364014621,0.00208088164532753
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23532.Phospholipids in Large LDL,28797,0.00715811778832858,0.00234408162104749,0.00256371781107551,0.0117525177655817,0.00226245740113739
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23533.Cholesterol in Large LDL,28797,0.00720971565339777,0.00235336544529475,0.00259711938062006,0.0118223119261755,0.00218910155780153
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,28797,0.00716681542837064,0.0023453735710687,0.00256988322907599,0.0117637476276653,0.00224722951757035
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23535.Free Cholesterol in Large LDL,28797,0.00720046048203897,0.00238040854915965,0.00253485972568605,0.0118660612383919,0.00248947595319915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23536.Triglycerides in Large LDL,28797,0.00422454444692397,0.00240398961776943,-0.000487275203904105,0.00893636409775205,0.0788763618476274
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23537.Concentration of Medium LDL Particles,28797,0.00677502121257719,0.00232606721947087,0.00221592946241428,0.0113341129627401,0.00358650647119121
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23538.Total Lipids in Medium LDL,28797,0.00677393779559898,0.00232504557811632,0.00221684846249099,0.011331027128707,0.00357717383725344
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23539.Phospholipids in Medium LDL,28797,0.00673843457891125,0.00232323102849182,0.00218490176306728,0.0112919673947552,0.00372899466796009
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23540.Cholesterol in Medium LDL,28797,0.00678358668909569,0.00232315275445817,0.00223020729035768,0.0113369660878337,0.00350312177334637
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,28797,0.00669963125937371,0.00232958946025988,0.00213363591726434,0.0112656266014831,0.00403192167106621
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,28797,0.00664831295436317,0.00232836041042268,0.00208472654993471,0.0112118993587916,0.00430184698201111
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23543.Triglycerides in Medium LDL,28797,0.00373752532754032,0.00242721211955908,-0.00101981042679546,0.00849486108187611,0.123609646990085
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23544.Concentration of Small LDL Particles,28797,0.00601816731530552,0.00232626840489098,0.00145868124171919,0.0105776533888918,0.00968507600737528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23545.Total Lipids in Small LDL,28797,0.0069035441305809,0.00232351205331994,0.00234946050607382,0.011457627755088,0.00296914730096731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23546.Phospholipids in Small LDL,28797,0.00730494293498261,0.00232310223791152,0.00275166254867603,0.0118582233212892,0.00166552797483945
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23547.Cholesterol in Small LDL,28797,0.00674807451410103,0.00232172714048478,0.00219748931875086,0.0112986597094512,0.00365788386573885
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,28797,0.00655577329771297,0.00232634911263347,0.00199612903695136,0.0111154175584746,0.00483488893335508
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23549.Free Cholesterol in Small LDL,28797,0.00658285192028748,0.00233037652219547,0.00201531393678436,0.0111503899037906,0.00473423960884691
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23550.Triglycerides in Small LDL,28797,0.00324444405452323,0.002454098968358,-0.00156558992345846,0.00805447803250492,0.186161666912052
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,28797,0.00514054365276259,0.00273880476388844,-0.00022751368445875,0.0105086009899839,0.0605378543474162
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23552.Total Lipids in Very Large HDL,28797,0.00410417610440344,0.00275130917438775,-0.00128838987739654,0.00949674208620342,0.135784173007536
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23553.Phospholipids in Very Large HDL,28797,0.00351087330566737,0.00274416127786872,-0.00186768279895533,0.00888942941029007,0.200767397832771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23554.Cholesterol in Very Large HDL,28797,0.00436694047371313,0.00275654575776977,-0.00103588921151563,0.00976977015894188,0.113157492498064
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,28797,0.00464508217041344,0.00278663538495131,-0.000816723184091129,0.010106887524918,0.0955423412052653
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,28797,0.00353676048639645,0.00261740243711052,-0.00159334829034018,0.00866686926313308,0.176626540769334
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23557.Triglycerides in Very Large HDL,28797,0.00414889577783427,0.00237168537103345,-0.000499607549391291,0.00879739910505983,0.0802420714406028
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23558.Concentration of Large HDL Particles,28797,0.0034972100312502,0.00283084433088796,-0.00205124485729021,0.0090456649197906,0.216693734441947
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23559.Total Lipids in Large HDL,28797,0.00292649572650906,0.00281058522431372,-0.00258225131314584,0.00843524276616395,0.297772596531501
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23560.Phospholipids in Large HDL,28797,0.00245082657766209,0.00277739934308035,-0.00299287613477539,0.00789452929009957,0.37755829053429
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23561.Cholesterol in Large HDL,28797,0.00305544379819647,0.00283059543677795,-0.00249252325788831,0.00860341085428124,0.280402898498571
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,28797,0.0028992958356202,0.00283089072727555,-0.00264924998983988,0.00844784166108027,0.305766515978406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23563.Free Cholesterol in Large HDL,28797,0.00347143757141464,0.00281367419923941,-0.0020433638590946,0.00898623900192388,0.217297270879564
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23564.Triglycerides in Large HDL,28797,0.00321451902115434,0.0024256809774206,-0.00153981569459003,0.00796885373689872,0.185114443725058
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23565.Concentration of Medium HDL Particles,28797,0.00232638049002865,0.0025608532282861,-0.0026928918374121,0.0073456528174694,0.363653616080191
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23566.Total Lipids in Medium HDL,28797,0.00213328274976605,0.00252889246397407,-0.00282334647962313,0.00708991197915524,0.398920074901109
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23567.Phospholipids in Medium HDL,28797,0.00187190181451837,0.00250020654030858,-0.00302850300448645,0.00677230663352319,0.454044842100406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23568.Cholesterol in Medium HDL,28797,0.00215778760618101,0.00257908056714156,-0.00289721030541644,0.00721278551777846,0.402796310476363
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,28797,0.00186448476533958,0.00257066745496854,-0.00317402344639876,0.00690299297707791,0.468278755202962
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,28797,0.00324724343485986,0.00260112712482149,-0.00185096572979026,0.00834545259950999,0.21189527956149
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23571.Triglycerides in Medium HDL,28797,0.0019811879014695,0.00240239642773505,-0.0027275090968912,0.00668988489983019,0.409564941815214
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23572.Concentration of Small HDL Particles,28797,0.00344042062789113,0.0023307487949147,-0.00112784701014167,0.00800868826592394,0.139927719791503
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23573.Total Lipids in Small HDL,28797,0.00305658619502181,0.00234717664490821,-0.00154388002899828,0.00765705241904191,0.192844938444964
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23574.Phospholipids in Small HDL,28797,0.00275381841532065,0.00235809895982822,-0.00186805554594266,0.00737569237658397,0.242891911656044
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23575.Cholesterol in Small HDL,28797,0.00332879855831127,0.00233147933749455,-0.00124090094317805,0.00789849805980059,0.153371104988315
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,28797,0.00249669033068907,0.00232551273705144,-0.00206131463393176,0.0070546952953099,0.283007169588416
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23577.Free Cholesterol in Small HDL,28797,0.00522220593582596,0.00237014855323679,0.000576714771481847,0.00986769710017008,0.027579790082245
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23578.Triglycerides in Small HDL,28797,0.00159215623691883,0.00251889469821614,-0.00334487737158482,0.00652918984542247,0.52733617989009
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,-0.00154758968363481,0.00241478967103472,-0.00628057743886286,0.00318539807159324,0.521606176002412
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,0.00286358267243814,0.00244697150570284,-0.00193248147873943,0.00765964682361571,0.241908154713465
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,0.00268390611371224,0.0024227038252964,-0.00206459338386871,0.00743240561129319,0.267951664694127
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,0.00185529253216083,0.00247491257445637,-0.00299553611377365,0.00670612117809531,0.453478180881387
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,-0.00125949708128827,0.00241114001361356,-0.00598533150797084,0.0034663373453943,0.601419863971993
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,28491,0.000373073352711766,0.0023447122731002,-0.00422256270256462,0.00496870940798815,0.873581260558076
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,28491,0.00361158570165683,0.00255591204283816,-0.00139800190230595,0.00862117330561962,0.157657222392295
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,28491,0.00367563606547643,0.00255182611044647,-0.00132594311099865,0.00867721524195151,0.149766838041651
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,28491,0.00286927772922714,0.00248346443040098,-0.00199831255435878,0.00773686801281306,0.247955652019845
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,28491,-0.00323020350396859,0.00249130790898681,-0.00811316700558275,0.00165275999764556,0.194782997208358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,28792,-0.00102156348217821,0.00247638724019281,-0.00587528247295612,0.00383215550859969,0.679960149431148
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,28792,0.00187371816989853,0.0023980999429255,-0.00282655771823545,0.0065739940580325,0.434612223745087
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,28792,0.00303727536432074,0.00248647380066896,-0.00183621328499042,0.0079107640136319,0.221899525691915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,28792,-0.00103618943532675,0.00235006537769774,-0.00564231757561431,0.00356993870496082,0.659274654783728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,28792,-0.000905475346679489,0.00232642624400667,-0.00546527078493257,0.00365432009157359,0.697121464550931
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,28797,0.00416660351974437,0.00245121513941423,-0.000637778153507526,0.00897098519299627,0.0891772047589721
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,28797,0.003617967,0.00256099,-0.001401574,0.008637507,0.1577483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,28797,0.00347597412256605,0.00257968895743542,-0.00158021623400737,0.00853216447913947,0.177849416957252
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,28797,0.0040250322071538,0.00250059844765655,-0.000876140750253046,0.00892620516456064,0.10749015171474
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,28797,-0.0037803237180569,0.00253967273655841,-0.00875808228171137,0.00119743484559758,0.136627874380103
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,28797,0.00387529902160035,0.00249296836058784,-0.00101091896515181,0.00876151700835251,0.120078131645967
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,28797,0.00358359462052032,0.00242004222408183,-0.00115968813868007,0.00832687737972071,0.138671252534866
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,28797,0.00315723504968895,0.00236259396175627,-0.00147344911535334,0.00778791921473125,0.181447869686499
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,28797,0.00389571295630039,0.00250856512502741,-0.00102107468875334,0.00881250060135413,0.120442575176362
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,28797,-0.0037041446303333,0.00244352408251839,-0.00849345183206934,0.00108516257140275,0.129554951828834
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,28797,-0.00169423962745897,0.00243862194183489,-0.00647393863345535,0.00308545937853741,0.487215787775969
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,28797,0.00305816837672784,0.00254972240231398,-0.00193928753180757,0.00805562428526324,0.230377545712964
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,28797,0.00315630894845177,0.00257514082226088,-0.00189096706317955,0.00820358496008309,0.220327635508903
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,28797,0.00231552849271627,0.00236130389766247,-0.00231262714670217,0.0069436841321347,0.326791196024124
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,28797,-0.00297572957126361,0.00253312725476122,-0.00794065899059561,0.00198919984806838,0.240114210672137
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,28797,-0.00186461883152433,0.00232612185125903,-0.00642381765999203,0.00269457999694337,0.422791105622115
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,28797,0.00320317634432178,0.00244897536568385,-0.00159681537241856,0.00800316806106213,0.190895310814046
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,28797,0.00409495368077121,0.00242972160973518,-0.000667300674309746,0.00885720803585217,0.091930129223985
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,28797,0.000139309209412706,0.00237911857007996,-0.00452376318794401,0.00480238160676943,0.953306986697757
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,28797,-0.00297560952978333,0.00250080400279291,-0.00787718537525743,0.00192596631569076,0.234110784155179
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,28797,-0.00178660005243435,0.00234120516299379,-0.00637536217190218,0.00280216206703349,0.445403291803646
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,28797,0.00446986439084241,0.0024882055680752,-0.00040701852258497,0.0093467473042698,0.072438090279908
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,28797,0.00339221667901762,0.0023270572971533,-0.00116881562340285,0.00795324898143809,0.144926429332545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,28797,0.00279342215404447,0.0025699301434234,-0.0022436409270654,0.00783048523515433,0.277061718079341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,28797,-0.00304243953906963,0.00246075554720241,-0.00786552041158635,0.00178064133344708,0.216325835806211
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,28797,-0.00218914081254224,0.00234415466400405,-0.00678368395399018,0.0024054023289057,0.350377667917604
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,28797,0.00467345455218504,0.00236666047596081,3.48000193018567e-05,0.00931210908506823,0.0483112599614608
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,28797,0.003622569822981,0.00238976263264665,-0.00106136493700644,0.00830650458296844,0.129563172840792
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,28797,9.01657182246073e-05,0.00255000113222362,-0.00490783650093369,0.00508816793738291,0.971793651354265
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,28797,-0.00302542772272493,0.00241031641506431,-0.00774964789625098,0.00169879245080112,0.209416573141853
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,28797,-0.00076066490451446,0.00235722367321005,-0.00538082330400616,0.00385949349497724,0.746928386676435
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,28797,0.00232142224558291,0.00234738775828423,-0.00227945776065419,0.00692230225182001,0.322701521125253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,28797,0.00154018636307718,0.0023540181293339,-0.00307368917041726,0.00615406189657162,0.512936825542709
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,28797,0.000730643238385653,0.00246205190655636,-0.00409497849846481,0.00555626497523612,0.7666504250942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,28797,-0.00208764222825528,0.00247111353950895,-0.00693102476569283,0.00275574030918226,0.398219252289742
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,28783,-0.000103402268175202,0.00263703376967788,-0.00527198845674385,0.00506518392039345,0.968721971032307
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,28783,-7.41375667471785e-05,0.00246176002315208,-0.00489918721212526,0.0047509120786309,0.975975007825517
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,28783,0.00100189467460729,0.00235946962428682,-0.00362266578899488,0.00562645513820946,0.671111731217705
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,28783,-0.00349239826215525,0.00277521941134486,-0.00893182830839118,0.00194703178408068,0.208249248793744
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,28783,0.000803206893155491,0.00260097131062509,-0.00429469687566969,0.00590111066198067,0.757468022197985
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,28797,-0.00421590687365044,0.00258608652375959,-0.00928463646021923,0.000852822712918351,0.103064569544954
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,28797,0.00135914945419734,0.00265191980276382,-0.00383861335921976,0.00655691226761443,0.608294352932756
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,28797,0.000185911685265413,0.00260954739197263,-0.00492880120300094,0.00530062457353177,0.943204945626359
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,28797,0.00520036739334665,0.00255861208674891,0.000185487703318776,0.0102152470833745,0.042112686191939
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,28797,0.000728508226147302,0.00255477609524083,-0.00427885292052472,0.00573586937281933,0.775527131697304
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,28797,-0.00225681807202426,0.0026128869878868,-0.00737807656828239,0.00286444042423388,0.387745699128032
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,28797,0.000407539568687467,0.00257260631231638,-0.00463476880345264,0.00544984794082758,0.874130863294236
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,28797,-0.00107375733412803,0.00250203183609071,-0.00597773973286582,0.00383022506460976,0.667814262761602
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,28797,0.00617046610072978,0.00272800415016063,0.000823577966414955,0.0115173542350446,0.0237111552746169
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,28797,0.000802746193869046,0.00251583827445649,-0.00412829682406567,0.00573378921180376,0.749670420079389
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,28797,-0.00179506301722518,0.00240146655614977,-0.00650193746727873,0.00291181143282836,0.45477625969832
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,28797,0.000863689951898914,0.0024004924142498,-0.0038412751800307,0.00556865508382852,0.719001591913892
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,28797,-0.000992239082481163,0.00238605756422856,-0.00566891190836914,0.00368443374340682,0.677523775541498
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,28797,0.0067414770862076,0.00250243616621102,0.001836702200434,0.0116462519719812,0.00706483756730676
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,28797,1.48156292529949e-05,0.00256061981526359,-0.00500399920866364,0.00503363046716963,0.995383542243725
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,49555,-0.00268134076631961,0.00197012654140403,-0.00654278878747151,0.00118010725483228,0.173520113838156
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,49555,-0.00310430532191166,0.00192123957565445,-0.00686993489019438,0.000661324246371066,0.106147709890937
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46216,-0.00228925930545936,0.00184360848256238,-0.00590273193128163,0.0013242133203629,0.21434343286709
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46216,-0.00289260048964905,0.00200735134003101,-0.00682700911610983,0.00104180813681173,0.149590445190888
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46216,-0.00310441121002957,0.00197981063173737,-0.00698484004823481,0.000776017628175676,0.116879948727708
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46216,-0.00140362289272819,0.00181662611292395,-0.00496421007405913,0.00215696428860274,0.439731305531478
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24009.Traffic intensity on the nearest road,49555,-0.0579008527633457,0.0512134788891776,-0.158279271386134,0.0424775658594425,0.258238058586111
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24010.Inverse distance to the nearest road,49555,-0.000495015106000422,0.00172029791011149,-0.00386679900981894,0.0028767687978181,0.773539591905634
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24011.Traffic intensity on the nearest major road,49555,-0.00182974643992769,0.00172241661407613,-0.0052056830035169,0.00154619012366152,0.288098561280909
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24012.Inverse distance to the nearest major road,49555,5.74045673715505e-05,0.00174888525390041,-0.00337041053027326,0.00348521966501636,0.973815455547566
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24013.Total traffic load on major roads,49555,0.00134264433647206,0.0337594047195086,-0.0648257889137648,0.0675110775867089,0.968275879244462
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24015.Sum of road length of major roads within 100m,49555,-0.0140748436823741,0.0330607212826494,-0.0788738573963668,0.0507241700316187,0.670308590970997
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,49555,-0.00123221705414621,0.00196874527232966,-0.00509095778791235,0.00262652367961993,0.531390285455633
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,49555,-0.00167992375239931,0.00196614350454795,-0.00553356502131329,0.00217371751651467,0.392873232960268
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,49555,-0.00156267773496196,0.00194522816566518,-0.00537532493966572,0.0022499694697418,0.421782650846439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,49456,-0.000833392352801527,0.00190720465652969,-0.00457151347959972,0.00290472877399667,0.662134582020561
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24020.Average daytime sound level of noise pollution,49555,-2.25169199147204e-07,0.00172959597944294,-0.00339023328890731,0.00338978295050901,0.999896127117211
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24021.Average evening sound level of noise pollution,49555,-2.53809002317603e-05,0.00172945666032706,-0.0034151159544728,0.00336435415400928,0.988291005035468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24022.Average night-time sound level of noise pollution,49555,-2.3205003657541e-06,0.00172961301892133,-0.00339236201745156,0.00338772101672005,0.998929540020648
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24023.Average 16-hour sound level of noise pollution,49555,-1.43568342242814e-05,0.00172950901512066,-0.00340419450386077,0.00337548083541221,0.99337678676191
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24024.Average 24-hour sound level of noise pollution,49555,-4.85449283127718e-06,0.00172952229888657,-0.00339471819864895,0.00338500921298639,0.997760479728353
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2405.Number of children fathered,22813,0.0765159545894758,0.0400463151436838,-0.00197482309214449,0.155006732271096,0.0560574074648266
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44217,0.00246361286718842,0.00204050223996259,-0.00153577152313826,0.0064629972575151,0.227301486984202
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44217,-0.00367392355671577,0.00184922673436104,-0.00729840795606341,-4.94391573681386e-05,0.0469579296127871
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24502.Water percentage, buffer 1000m",44217,0.000737952571028963,0.00183904203179794,-0.00286656981129499,0.00434247495335292,0.688223218118686
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44217,0.00342940755191116,0.00191876769986344,-0.000331377139821181,0.00719019224364351,0.0738963647942564
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44217,-0.00396385778428167,0.00186363302990107,-0.00761657852288776,-0.000311137045675573,0.0334296030890478
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24505.Water percentage, buffer 300m",44217,0.00215378868262514,0.00184939188572202,-0.00147101941339002,0.0057785967786403,0.244190099178785
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",49792,0.00179697979069536,0.0019486324815866,-0.00202233987321438,0.00561629945460511,0.356441869097994
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24507.Natural environment percentage, buffer 300m",49792,0.00162373491418141,0.00183124256073501,-0.0019655005048592,0.00521297033322203,0.37525291647807
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24508.Distance (Euclidean) to coast,49792,0.000891576319967066,0.001743225695615,-0.00252514604343833,0.00430829868337247,0.6090368390215
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,10954,-0.00330598802603034,0.0474300882393295,-0.0962689609751162,0.0896569849230555,0.944431855078063
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2704.Years since last cervical smear test,20568,-0.0360764358399837,0.0334465044632887,-0.10163158458803,0.0294787129080621,0.2807649234995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2714.Age when periods started (menarche),26242,0.00185184150529752,0.0290576027417903,-0.0551010598686115,0.0588047428792065,0.94918568918848
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2734.Number of live births,27063,-0.00584616769307904,0.0278160345051384,-0.0603655953231503,0.0486732599369922,0.833534564249165
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2744.Birth weight of first child,21469,0.0223630287745214,0.0306548278328105,-0.0377204337777871,0.0824464913268299,0.46569721483595
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2754.Age at first live birth,18262,0.00334802087627925,0.00308814278115232,-0.0027047389747793,0.00940078072733781,0.278311057668972
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2764.Age at last live birth,18214,0.00352746007267206,0.00298409680365273,-0.00232136966248729,0.00937628980783142,0.237186886337274
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2794.Age started oral contraceptive pill,20743,0.00278883693297666,0.00339346189117969,-0.00386234837373553,0.00944002223968885,0.411185097033506
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2804.Age when last used oral contraceptive pill,18828,0.000420748317438398,0.00296551018517737,-0.00539165164550925,0.00623314828038605,0.887175849823538
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2867.Age started smoking in former smokers,12251,0.000460792450663981,0.00353994551708185,-0.00647750076281645,0.00739908566414442,0.896434573197384
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19101,-0.0476134192684103,0.0429293687586895,-0.131754982035442,0.0365281434986211,0.26739643483628
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19094,-0.0670498579316785,0.0485131441443556,-0.162135620454615,0.0280359045912584,0.166958183229353
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19131,0.0242107657407073,0.0473367435092498,-0.0685692515374222,0.116990783018837,0.609036156863402
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19077,0.00699161849016487,0.0468188636086712,-0.0847733541828307,0.0987565911631604,0.881292168148316
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28739.Difficulty with standing for long periods,19151,0.0409665559994097,0.0395091163547212,-0.0364713120558439,0.118404424054663,0.299800837716607
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28740.Difficulty with taking care of household responsibilities,19195,0.0704351618563676,0.0432991914462847,-0.0144312533783505,0.155301577091086,0.103815456110072
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28741.Difficulty learning a new task,19040,-0.05792681885874,0.0527335056069168,-0.161284489848297,0.0454308521308169,0.272007875524915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28742.Difficulty with joining in community activities,18348,0.0341285253717309,0.0505312848688943,-0.064912792971302,0.133169843714764,0.49943401134768
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28743.Difficulty with being emotionally affected by health problems,19066,0.0306359333632941,0.0428608855585248,-0.0533714023314146,0.114643269058003,0.474756211874167
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19193,-0.0384931502994239,0.0647239250705857,-0.165352043437772,0.088365742838924,0.552032114877317
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11630,0.0788329575332427,0.0511167946874977,-0.0213559600542527,0.179021875120738,0.123049216294283
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2897.Age stopped smoking,12259,0.00198856008538688,0.0036809754990078,-0.0052261518926684,0.00920327206344216,0.58905074395582
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17131,0.00572320176249687,0.00625272756926342,-0.00653214427325943,0.0179785477982532,0.360040319939323
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17131,0.000894064802988181,0.00681488917252285,-0.0124631179751566,0.014251247581133,0.895624285638051
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17131,-0.0260347604424059,0.022829642616686,-0.0707808599711104,0.0187113390862987,0.254138640253519
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17131,0.026081726976026,0.0233508068855648,-0.0196858545196809,0.0718493084717329,0.264030590643939
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17131,-0.0201650808692215,0.0261087641190789,-0.0713382585426161,0.0310080968041732,0.439918346486604
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17131,-0.0115656090138768,0.0220640435180968,-0.0548111343093466,0.031679916281593,0.600157657361338
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17131,-0.00251254424723629,0.00983266765945125,-0.0217845728597607,0.0167594843652882,0.79831663564995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17131,-0.0149928608896965,0.0178579655398711,-0.0499944733478438,0.0200087515684507,0.401166001376615
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29002.Recent lack of interest or pleasure in doing things,17019,0.0594479863298018,0.0478156025806503,-0.0342705947282727,0.153166567387876,0.213783324484668
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29003.Recent feelings of depression,17007,0.0503971348637367,0.046381383261556,-0.0405103763289131,0.141304646056386,0.277237391919691
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17031,-0.0580541310153128,0.0389937300932731,-0.134481841998128,0.0183735799675024,0.136556781192571
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29005.Recent feelings of tiredness or low energy,17037,-0.029038293904234,0.0386264268206889,-0.104746090472784,0.0466695026643163,0.452198145550748
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29006.Recent poor appetite or overeating,17050,-0.0456989395598408,0.0561666502222207,-0.155785573995393,0.0643876948757118,0.415867625865364
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29007.Recent feelings of inadequacy,16981,0.038764485803807,0.0514377330084687,-0.0620534708927917,0.139582442500406,0.451088106716655
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29008.Recent trouble concentrating on things,17045,0.0189300911989593,0.0509663062211439,-0.0809638689944827,0.118824051392401,0.710326638304622
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17030,0.0455289307076509,0.0875562225766631,-0.126081265542609,0.21713912695791,0.603072768683074
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29010.Recent thoughts of suicide or self-harm,16946,0.0770214908260368,0.0948702482676271,-0.108924195778512,0.262967177430586,0.416882590466301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#0.Substances taken for depression_None of options listed,15725,0.01482410044491,0.011969444067424,-0.00863600992724111,0.0382842108170611,0.215550961066109
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),15725,-0.0176476638007334,0.0230308027577452,-0.0627880372059139,0.0274927096044471,0.443531037134918
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),15725,-0.00104116642764184,0.0118551921236907,-0.0242773429900756,0.0221950101347919,0.930017947379945
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),15725,-0.0479293532844454,0.0346878241818839,-0.115917488680938,0.020058782112047,0.167072973472292
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),15725,0.0052825004729893,0.0221230989668054,-0.0380787735019493,0.0486437744479279,0.811281154935899
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),15725,-0.00618911994910918,0.0238349042646805,-0.0529055323078829,0.0405272924096645,0.795124639233158
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),15725,0.000375850549972571,0.0264092025946768,-0.051386186535594,0.0521378876355392,0.988645228702417
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),15725,-0.0349633658373062,0.0316130283697295,-0.096924901441976,0.0269981697673637,0.268752265317289
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),15725,-0.0090568715774184,0.0233472604552759,-0.0548175020697592,0.0367037589149224,0.698080419581595
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,15725,-0.0147281875361495,0.0117471694533595,-0.0377526396647341,0.00829626459243517,0.209946163089863
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,15725,0.0382772901297414,0.0180498856181921,0.0028995143180848,0.073655065941398,0.0339678223730386
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,15725,0.00122307629893507,0.0285384327018058,-0.0547122517966043,0.0571584043944744,0.965815939918185
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,15725,-0.0350178460997909,0.0366763141510096,-0.10690342183577,0.036867729636188,0.339703172458392
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,15725,0.0354183591978548,0.0228873551618872,-0.00944085691944412,0.0802775753151536,0.121761001901108
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,15725,-0.00983395198491017,0.0371857640826725,-0.0827180495869482,0.0630501456171279,0.791432996278483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,15725,-0.063892053833384,0.0365144167659448,-0.135460310694636,0.0076762030278678,0.0801764780065636
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,15725,0.00436086712147702,0.0197253175601955,-0.0343007552965062,0.0430224895394603,0.825033255826949
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,15725,0.0113951504743136,0.0190946508184309,-0.0260303651298109,0.0488206660784381,0.550668300345122
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,15725,-0.0190565352428929,0.0272426922902129,-0.0724522121317102,0.0343391416459245,0.484243732031471
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29058.Recent feelings or nervousness or anxiety,16771,0.00724789267072107,0.0448842228862076,-0.0807251841862458,0.095220969527688,0.871717513580038
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29059.Recent inability to stop or control worrying,16791,-0.00674415519599639,0.0472816967263698,-0.0994162807796812,0.0859279703876884,0.886577989199418
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29060.Recent worrying too much about different things,16781,-0.0120067412232533,0.0435111255877733,-0.0972885473752891,0.0732750649287824,0.782592587428469
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29061.Recent trouble relaxing,16784,-0.0180341427341914,0.0461149501217668,-0.108419444972854,0.0723511595044715,0.695750957449699
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29062.Recent restlessness,16802,-0.0628900649819773,0.0690797745197913,-0.198286423040768,0.0725062930768137,0.362625904404855
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29063.Recent easy annoyance or irritability,16759,-0.0251854202722667,0.0471707542650736,-0.117640098631811,0.0672692580872776,0.593403808885521
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29064.Recent feelings of foreboding,16747,0.0418142796834772,0.0515504739670497,-0.0592246492919403,0.142853208658895,0.417300956615399
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,15725,-0.0150104857180389,0.0125163275251744,-0.0395424876673808,0.00952151623130298,0.230440143211837
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,15725,-0.036326649057184,0.0208593027922366,-0.0772108825299678,0.00455758441559985,0.0816140908936177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',15725,-0.0239721933323626,0.0269954754660074,-0.0768833252457371,0.028938938581012,0.374550138879771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,15725,-0.0451160130644945,0.0286840435258006,-0.101336738375064,0.0111047122460748,0.115771146185991
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#2.Symptoms of panic attack_Sweating,15725,-0.0040230823712328,0.0188931701929389,-0.041053695949393,0.0330075312069274,0.831377734253831
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,15725,-0.00818404047078146,0.0203595126883129,-0.0480886853398747,0.0317206043983117,0.687706976566999
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,15725,0.0122992500728878,0.0203597520165077,-0.0276058638794674,0.0522043640252429,0.545788367677413
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,15725,-0.0018841735028799,0.0189165287827237,-0.0389605699170184,0.0351922229112586,0.920659503304891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,15725,0.0118024876564742,0.0248304426397909,-0.0368651799175159,0.0604701552304643,0.634563170112234
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29076.Felt loved as a child,16720,0.026586652341978,0.0403881425772538,-0.0525741071094396,0.105747411793396,0.510368161229543
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29077.Physically abused by family as a child,16750,-0.0570769340856409,0.0574148695949142,-0.169610078491673,0.0554562103203909,0.320181674041567
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29078.Felt hated by family member as a child,16721,0.000540035016976162,0.0547728393853565,-0.106814730178323,0.107894800212275,0.99213347021867
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29079.Sexually molested as a child,16595,-0.0434983856281187,0.0761448876966807,-0.192742365513613,0.105745594257375,0.567832427982868
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29080.Someone to take to doctor when needed as a child,16688,0.132186041414983,0.0654846608721388,0.00383610610559115,0.260535976724375,0.0435468484132184
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,16726,0.0206626272112815,0.0758751014166782,-0.128052571565408,0.169377825987971,0.785376105455609
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29082.Belittlement by partner or ex-partner as an adult,16621,-0.153932911317756,0.0666640531295735,-0.28459445545172,-0.0232713671837923,0.0209511228055804
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29083.Physical violence by partner or ex-partner as an adult,16739,0.0120926170903541,0.0664476472368029,-0.11814477149378,0.142330005674488,0.855595026059377
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,16690,0.0547823681815384,0.0889531850075342,-0.119565874433229,0.229130610796305,0.537997854657315
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,16688,0.0568066310131448,0.0857289952391235,-0.111222199655537,0.224835461681827,0.507576510148489
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29086.Experienced a violent or sexual assault,16742,-0.0249814346364096,0.0783059579241004,-0.178461112167646,0.128498242894827,0.749712735680554
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29087.Experienced a life-threatening injury or illness,16739,-0.0866275332922269,0.0503226226493507,-0.185259873684954,0.0120048071005004,0.0851889357194047
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29088.Experienced a marital separation or divorce,16747,0.0348215836765802,0.0438629567271435,-0.0511498115086211,0.120792978861781,0.427281070694854
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29089.Experienced the death of a spouse or partner,16767,0.0831924003165132,0.0558631643393079,-0.0262994017885304,0.192684202421557,0.136448936803989
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,16745,-0.012221363226974,0.0562438524532365,-0.122459314035317,0.0980165875813695,0.827983107938881
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29091.Frequency of drinking alcohol,16748,0.049216385600149,0.03671413227519,-0.0227433136592234,0.121176084859521,0.180091388901434
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,14943,-0.00537838178978847,0.0415319046231686,-0.086780914851199,0.076024151271622,0.896963767218043
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,14980,0.00847095199435613,0.0422711723639898,-0.0743805458390639,0.0913224498277762,0.841174015527332
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29104.Ever used cannabis,16738,0.028692408152243,0.0528319193434303,-0.0748581537608805,0.132242970065366,0.58707610513286
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29108.Ever thought that life not worth living,16659,-0.0275470903876042,0.0469717889455813,-0.119611796720944,0.0645176159457352,0.557574172374242
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29109.Ever contemplated self-harm,16698,-0.0940758300768039,0.0676211496419742,-0.226613283375073,0.0384616232214655,0.164177570837332
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29111.Ever self-harmed,16724,0.019111829376947,0.101460973699854,-0.179751679074766,0.21797533782866,0.850591794017149
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,16720,-0.0885562777804026,0.0734931380587899,-0.232602828375631,0.0554902728148257,0.22823588646352
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,16998,-0.00320792915851987,0.0262192721555023,-0.0545977025833044,0.0481818442662647,0.902623246160843
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,16998,-0.017334959561691,0.0202530531350975,-0.0570309437064821,0.0223610245831002,0.39205502620443
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,16998,-0.0074799539167352,0.0217211273301847,-0.0500533634838972,0.0350934556504268,0.730577527832201
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,16998,-0.0191618030104341,0.0292818597453426,-0.0765542481113055,0.0382306420904374,0.512868406666228
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,16705,0.0266710069200609,0.0407599177457683,-0.053218431861645,0.106560445701767,0.512899231648528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X29153.Pain or discomfort today,16731,-0.0159441678472368,0.039205412768047,-0.092786776872609,0.0608984411781354,0.684246166976995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29154.Anxiety or depression today,16731,0.00814624513179328,0.0483724918785281,-0.0866638389501218,0.102956329213708,0.866265482526297
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29166.Frequency of confiding in someone close,16314,-0.0354218394191194,0.0375992751797246,-0.10911641877138,0.0382727399331408,0.346161369790454
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,16678,-0.00248241896851884,0.00632056844473468,-0.0148707331201988,0.00990589518316114,0.694507324798149
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,16678,0.00849463622094291,0.0063422542016164,-0.00393618201422524,0.0209254544561111,0.180467942488352
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,16678,-0.00153638489250215,0.00788932394808056,-0.01699945983074,0.0139266900457357,0.845597088963626
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,16678,-0.0119816271777279,0.00855104972598096,-0.0287416846406506,0.00477843028519478,0.161176522292664
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,16678,-0.00701640256880772,0.0137984222592869,-0.0340613101970101,0.0200285050593947,0.611114305311785
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,16678,0.00216641096585321,0.00653095581964501,-0.010634262440651,0.0149670843723574,0.740109227893301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,16674,0.00201800995121726,0.00711751082794651,-0.0119323112715579,0.0159683311739924,0.776776038030695
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,16674,-0.00605330941697846,0.0104066772909984,-0.0264503969073352,0.0143437780733783,0.560793134268569
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,16674,0.0124360095007386,0.0160554805032252,-0.0190327322855829,0.04390475128706,0.438607876100207
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,16674,-0.0109579484671793,0.0144019261038827,-0.0391857236307894,0.0172698266964309,0.446747355840523
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,16674,-0.0103011812804989,0.0212937364298026,-0.052036904682912,0.0314345421219141,0.628558452822908
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,16674,-0.00305853747275964,0.0102183111152523,-0.0230864272586541,0.0169693523131348,0.764700182946397
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29171.Frequency of feeling 'in tune' with people,16394,0.0791399372534981,0.0502828465712532,-0.0194144420261583,0.177694316533154,0.115530964846441
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29172.Freuency of feeling that lacks companionship,16612,0.0558683980334178,0.0423897056207427,-0.0272154249832378,0.138952221050073,0.187531583098254
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29173.Frequency of feeling left out,16525,0.0211693410376282,0.0446484868478758,-0.0663416931842085,0.108680375259465,0.635411017920019
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29174.Frequency of feeling isolated from others,16588,0.0202816377626074,0.046530459637181,-0.0709180631262673,0.111481338651482,0.662930393521522
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29175.Tendency to bounce back quickly after hard times,16709,0.00117617929380696,0.0373811503210318,-0.0720908753354154,0.0744432339230293,0.974899477291891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29176.Ability to make it through stressful events,16709,0.0488666210786167,0.0373133906300447,-0.0242676245562709,0.122000866713504,0.190340099557006
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29177.Quick recovery from stressful events,16709,0.0338443656019098,0.0372758944596262,-0.0392163875389575,0.106905118742777,0.363921754874268
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29178.Hard to snap back when something bad happens,16709,-0.0224125550796897,0.0368863594795247,-0.0947098196595582,0.0498847095001787,0.543453817713115
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29179.Comes through difficult times with little trouble,16709,0.041865274752705,0.0366606739519971,-0.0299896461932092,0.113720195698619,0.253484175639819
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29180.Tendency to take a long time to get over setbacks,16709,-0.0204232987136236,0.0367898235668876,-0.0925313529047232,0.051684755477476,0.578810135126995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29181.General happiness,16615,0.0609560282958928,0.0389897702768683,-0.0154639214467691,0.137375978038555,0.117981093878389
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29182.Belief that own life is meaningful,16423,-0.0877736061592622,0.0390079363432055,-0.164229161391945,-0.0113180509265793,0.0244527843982545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11146,-0.0546011606265827,0.0471524137450901,-0.147019891566959,0.0378175703137938,0.246900431409302
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2946.Father's age,10982,0.00321961617451792,0.00556843483782767,-0.00769451610762431,0.0141337484566601,0.563147376434886
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2966.Age high blood pressure diagnosed,12573,-0.00184173930176456,0.00406232209586078,-0.00980389060965168,0.00612041200612256,0.650289399983792
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30000.White blood cell (leukocyte) count,48656,0.00199620596486215,0.00184457784925841,-0.00161916661968433,0.00561157854940864,0.2791681141484
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48657,0.00245219117893329,0.00205909050056476,-0.00158362620217364,0.00648800856004023,0.233694784724874
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30020.Haemoglobin concentration,48657,0.00342153410795589,0.00220455864711577,-0.000899400840391034,0.0077424690563028,0.120662316316059
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30030.Haematocrit percentage,48657,0.00358126124309606,0.00215327770637776,-0.000639163061404344,0.00780168554759646,0.0962853773071523
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30040.Mean corpuscular volume,48657,0.00146705883297093,0.00181928620646596,-0.00209874213170234,0.00503285979764421,0.420020486818942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48656,0.000906409784738365,0.00182550918079849,-0.00267158820962667,0.0044844077791034,0.619526745940487
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48656,-0.00105833981564535,0.00178184758690555,-0.00455076108598023,0.00243408145468952,0.552544022830967
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48657,0.00195183681923697,0.00178012834735349,-0.00153721474157587,0.00544088838004981,0.272883612678618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30080.Platelet count,48657,0.00142332785238015,0.00182274613390631,-0.00214925457007621,0.00499591027483651,0.434882732824863
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30090.Platelet crit,48657,0.00122869006970756,0.00186436992849003,-0.0024254749901329,0.00488285512954802,0.509874679475578
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48657,-0.00126088241903319,0.00174882137942398,-0.00468857232270419,0.00216680748463781,0.470919240463998
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30110.Platelet distribution width,48657,0.00101581844580728,0.00176782656380209,-0.0024491216192448,0.00448075851085937,0.565554827449724
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30120.Lymphocyte count,48584,-0.00125334003710142,0.00181850355853351,-0.00481760701182711,0.00231092693762427,0.490691234100677
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30130.Monocyte count,48584,0.00134501241765941,0.00183017242710869,-0.00224212553947361,0.00493215037479244,0.462397723114624
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30140.Neutrophill count,48584,0.00255724100583217,0.00182455499304884,-0.00101888678054356,0.00613336879220789,0.161050168419234
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30150.Eosinophill count,48584,-0.0041365560620145,0.00177710476054758,-0.00761968139268775,-0.000653430731341251,0.0199324450081181
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30160.Basophill count,48584,0.0141936327124358,0.024052559714688,-0.0329493843283527,0.0613366497532242,0.555120299780345
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30170.Nucleated red blood cell count,48584,-0.101606039679643,0.128286591531613,-0.353047759081604,0.149835679722318,0.428350640037347
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30180.Lymphocyte percentage,48585,-0.00269281690419757,0.00178780828772414,-0.00619692114813689,0.000811287339741751,0.132019462908378
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30190.Monocyte percentage,48585,8.00873859776773e-05,0.001810929903105,-0.00346933522410813,0.00362950999606348,0.964725671540568
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30200.Neutrophill percentage,48585,0.00299172921185521,0.00177015709615116,-0.000477778696601053,0.00646123712031148,0.0910166787341898
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30210.Eosinophill percentage,48585,-0.00464405152524767,0.0017576046498677,-0.00808895663898837,-0.00119914641150697,0.00823807830066156
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30220.Basophill percentage,48585,-0.000619035290298006,0.00174881674042277,-0.00404671610152663,0.00280864552093061,0.72336006195941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30230.Nucleated red blood cell percentage,48583,-0.094330564408471,0.127655039084494,-0.344534441014078,0.155873312197137,0.459941533131385
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30240.Reticulocyte percentage,47806,-0.00045216438278629,0.00188758213852256,-0.00415182537429051,0.00324749660871793,0.810682588658108
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30250.Reticulocyte count,47806,-9.35880171773798e-05,0.00192794922866932,-0.00387236850536925,0.00368519247101449,0.961283873148106
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30260.Mean reticulocyte volume,47806,0.00123309965185819,0.00179741100135245,-0.00228982591079262,0.004756025214509,0.492689876779009
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30270.Mean sphered cell volume,47806,0.000939578095958148,0.00181298486062028,-0.00261387223085759,0.00449302842277389,0.604286755894393
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30280.Immature reticulocyte fraction,47806,-0.000273946815818635,0.00188623422909298,-0.00397096590484087,0.0034230722732036,0.884526117977948
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47806,-0.000504521915751018,0.00192686732329716,-0.00428118186941345,0.00327213803791141,0.793449538287068
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30300.High light scatter reticulocyte count,47806,-8.82397541141584e-05,0.0019561494981317,-0.00392229277045228,0.00374581326222396,0.964020695112265
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30500.Microalbumin in urine,15751,-0.00372561553080238,0.00294723671238727,-0.00950219948708144,0.00205096842547667,0.206211203180639
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48759,9.30348353698405e-05,0.00189581229096025,-0.00362275725491224,0.00380882692565193,0.960860632518769
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30520.Potassium in urine,48659,0.000714718420585135,0.0017658293987009,-0.00274630720086864,0.00417574404203891,0.685663492981517
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30530.Sodium in urine,48647,0.0017153196827417,0.00183906756872838,-0.00188925275196593,0.00531989211744932,0.350973516449256
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30600.Albumin,43838,0.00555423611478901,0.00194300005959739,0.00174595599797812,0.0093625162315999,0.00425732061025184
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30610.Alkaline phosphatase,47830,-0.000727358295404313,0.00183710139200286,-0.00432807702372991,0.00287336043292129,0.692160547221378
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30620.Alanine aminotransferase,47826,-0.00628001972330844,0.00194565670633493,-0.0100935068677249,-0.00246653257889198,0.00124868559318564
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30630.Apolipoprotein A,43569,0.00158757489757285,0.00212358803461569,-0.00257465765027391,0.00574980744541961,0.454711046057826
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30640.Apolipoprotein B,47574,0.0037965685920022,0.00177369788251985,0.000320120742263298,0.0072730164417411,0.0323208950040948
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30650.Aspartate aminotransferase,47683,-0.00652036718390157,0.00184643773086563,-0.0101393851363982,-0.00290134923140494,0.000413877336424952
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30660.Direct bilirubin,40608,-0.00134980869847308,0.00198366851002482,-0.00523779897812172,0.00253818158117556,0.496216603577025
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30670.Urea,47810,0.000929401813178038,0.00187646547568731,-0.00274847051916909,0.00460727414552517,0.62039498720812
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30680.Calcium,43836,0.00348846096596166,0.00188220576851108,-0.000200662340320067,0.00717758427224338,0.0638332252714704
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30690.Cholesterol,47841,0.00587593931157092,0.00180495465635361,0.00233822818511785,0.00941365043802399,0.00113291599960461
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30700.Creatinine,47822,-0.000531116139568021,0.00217812681641931,-0.00480024469974987,0.00373801242061383,0.80735518263869
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30710.C-reactive protein,47697,-0.00107917770515247,0.00198513776118136,-0.00497004771706793,0.00281169230676299,0.586699601301723
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30720.Cystatin C,47843,0.000110394282122708,0.00208317111166187,-0.00397262109673456,0.00419340966097997,0.957737402164343
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30730.Gamma glutamyltransferase,47820,-0.00275903880376824,0.00198068252388682,-0.00664117655058642,0.00112309894304993,0.163634199790274
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30740.Glucose,43784,-0.000320582018762625,0.00193433486589934,-0.00411187835592534,0.00347071431840009,0.868368288559818
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47576,-0.00299303759030172,0.00190856170952878,-0.00673381854097812,0.000747743360374685,0.116837313126032
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30760.HDL cholesterol,43809,0.00307526330642305,0.00222354320624963,-0.00128288137782623,0.00743340799067232,0.166657706440731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30770.IGF-1,47590,0.00270993890081174,0.00186185167286991,-0.00093929037801327,0.00635916817963676,0.145535439289005
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30780.LDL direct,47734,0.00544083310077666,0.00178135547709986,0.00194937636566093,0.00893228983589238,0.00225694180352367
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30790.Lipoprotein A,38263,0.000583389893885301,0.00198901814910407,-0.00331508567835868,0.00448186546612928,0.769290267746141
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30810.Phosphate,43737,-0.00266724796441163,0.00194768880335617,-0.00648471801898972,0.00115022209016646,0.170868007998988
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30830.SHBG,43427,0.00292690427016699,0.00225086355636942,-0.00148478830031707,0.00733859684065105,0.193488878327815
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30840.Total bilirubin,47648,0.000344247923878678,0.00189242825766589,-0.00336491146114646,0.00405340730890382,0.855655665209123
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30850.Testosterone,43206,0.00800850179626727,0.00308508129104232,0.00196174246582432,0.0140552611267102,0.00943808524177592
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30860.Total protein,43805,-0.0014388696435346,0.00191415598233622,-0.00519061536891359,0.00231287608184439,0.452235972851483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30870.Triglycerides,47806,-0.000702115751957729,0.00193765840243365,-0.00449992622072768,0.00309569471681222,0.717090084021435
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30880.Urate,47778,-0.00329198743682402,0.00222862055597717,-0.00766008372653926,0.00107610885289123,0.139644361289171
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30890.Vitamin D,45680,-0.00198635154511255,0.00198191607253782,-0.00587090704728667,0.00189820395706157,0.316233982911337
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3137.Number of measurements made,45499,0.0136848687057887,0.0280935834325946,-0.0413785548220967,0.0687482922336741,0.626177600145825
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3143.Ankle spacing width,28468,-0.00330261657066062,0.0031214528066299,-0.00942066407165523,0.00281543093033399,0.290046970976922
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",28466,-0.00113461053426929,0.00240852568569176,-0.00585532087822513,0.00358609980968655,0.637586550180637
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3146.Speed of sound through heel,28468,-0.00180159666927175,0.00232793517340918,-0.00636434960915374,0.00276115627061024,0.438994418786161
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",28468,-0.00159298916219829,0.00235213103848352,-0.00620316599762598,0.00301718767322941,0.498250584996939
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3148.Heel bone mineral density (BMD),28447,-0.0016112077186034,0.00235587775910494,-0.00622872812644908,0.00300631268924229,0.494037744043235
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X3526.Mother's age at death,29913,-0.0007658953,0.002267851,-0.005210884,0.003679093,0.7355777
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X3581.Age at menopause (last menstrual period),15493,0.00173339736729003,0.00324666166867333,-0.00463005950330969,0.00809685423788975,0.593417386286026
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",9883,-0.00228881707061022,0.00387934257879506,-0.00989232852504854,0.00531469438382811,0.555203302037387
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4100.Ankle spacing width (left),16122,0.00471031996412493,0.00443280973073653,-0.00397798710811866,0.0133986270363685,0.287977644309261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16118,0.00048292903235411,0.0034146756303971,-0.0062098352032242,0.00717569326793242,0.887534001013646
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4103.Speed of sound through heel (left),16122,-0.00148253749751383,0.00329933036590725,-0.00794922501469204,0.00498415001966437,0.653188869231668
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16122,-0.000910747866235446,0.00333387534791556,-0.00744514354814995,0.00562364781567906,0.784718401738529
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4105.Heel bone mineral density (BMD) (left),16112,-0.00119463481235137,0.00333496434602775,-0.00773116493056577,0.00534189530586303,0.720186994189676
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16122,-0.000910643793794526,0.00333388003115398,-0.00744504865485633,0.00562376106726728,0.78474269138219
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4119.Ankle spacing width (right),16116,0.0042609734755485,0.00437412278445291,-0.0043123071819792,0.0128342541330762,0.330005579554964
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16115,-0.00151296150755113,0.00343682060049835,-0.00824912988452789,0.00522320686942564,0.659782769960918
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4122.Speed of sound through heel (right),16116,-0.00178691823227717,0.00331430151232495,-0.00828294919643408,0.00470911273187974,0.589788194682251
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16116,-0.00191398428084034,0.0033522858508589,-0.00848446454852378,0.00465649598684311,0.568042176839407
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4124.Heel bone mineral density (BMD) (right),16102,-0.00128397187662439,0.00335583104435528,-0.00786140072356074,0.00529345697031196,0.702014592220234
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16116,-0.00191270746474541,0.00335228715366301,-0.00848319028592491,0.00465777535643409,0.568300540060429
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4194.Pulse rate,16758,0.000361206652218417,0.00316437100418561,-0.00584096051598538,0.00656337382042222,0.909121833243988
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4195.Pulse wave reflection index,16758,-0.00282285969365204,0.00324600289731279,-0.0091850253723851,0.00353930598508102,0.384508671274163
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4196.Pulse wave peak to peak time,16747,-0.0033225996197166,0.00323244672372837,-0.0096581951982242,0.003012995958791,0.304016438240561
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4198.Position of the pulse wave peak,16758,0.00235908856508224,0.00325684639638077,-0.00402433037182408,0.00874250750198855,0.468862539190547
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4199.Position of pulse wave notch,16758,0.00191267297802182,0.00315828466713134,-0.00427756496955561,0.00810291092559926,0.544785291345363
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4200.Position of the shoulder on the pulse waveform,16758,0.00420550110438035,0.00327544155111714,-0.00221436433580925,0.0106253665445699,0.199177438621617
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4269.Number of triplets attempted (left),16441,-0.176168289406925,0.0893450935847896,-0.351284672833112,-0.00105190598073729,0.0486522331172833
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4270.Volume level set by participant (left),16266,-0.00191165541627432,0.0357858234724433,-0.0720518694222632,0.0682285585897145,0.957398445138322
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4276.Number of triplets attempted (right),16449,-0.165228692721238,0.0871365733619306,-0.336016376510622,0.00555899106814595,0.0579506496262791
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4277.Volume level set by participant (right),16256,0.00450998567980392,0.0350881690114725,-0.0642628255826822,0.07328279694229,0.89772882020414
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X4288.Time to answer,16795,-0.000241643229998582,0.0036507971194351,-0.00739720558409138,0.00691391912409421,0.947228007696003
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X4290.Duration screen displayed,16795,0.00390217018976597,0.00333745791563678,-0.00263924732488212,0.0104435877044141,0.242337931289033
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X46.Hand grip strength (left),50032,0.00424232854501224,0.00249129813768503,-0.000640615804850413,0.00912527289487489,0.0886007397405552
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X47.Hand grip strength (right),50038,0.00375293897966103,0.00247145036561848,-0.00109110373695119,0.00859698169627325,0.128890479140349
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X48.Waist circumference,50176,-0.001717843,0.003853267,-0.009270247,0.00583456,0.655733
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X4803.Tinnitus,16497,-0.0203209013730311,0.0432244955345787,-0.105040912620805,0.0643991098747432,0.63827217600496
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X4825.Noisy workplace,16700,0.0253568028474439,0.0471615766943022,-0.0670798874733885,0.117793493168276,0.590820295057916
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X4836.Loud music exposure frequency,16602,-0.00174551070151356,0.0600141110772842,-0.119373168412991,0.115882147009963,0.976797145207032
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X49.Hip circumference,50167,-0.00173198036650373,0.00308771014044746,-0.00778389224178075,0.0043199315087733,0.574849724911144
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X50.Standing height,50124,0.00158522404560548,0.00245131059291092,-0.00321934471649992,0.00638979280771087,0.517839255853495
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X5057.Number of older siblings,14725,-0.0106000735645935,0.0386223085371338,-0.0862997982973757,0.0650996511681887,0.783739076359696
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X51.Seated height,49898,0.000501495136807854,0.00228063657803319,-0.0039685525561372,0.00497154282975291,0.825955689150537
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5181.Ever had eye surgery,11336,0.0501461254685719,0.0840742422117263,-0.114639389266412,0.214931640203555,0.550886226521463
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5186.Duration visual-acuity screen displayed (right),11307,-0.00200435684435651,0.00378034163523233,-0.00941382644941189,0.00540511276069886,0.595980081098296
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5188.Duration visual-acuity screen displayed (left),11305,-0.00242364371801774,0.0038134763498511,-0.00989805736372589,0.00505076992769041,0.525084558470176
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5190.Duration at which refractometer first shown (right),11178,-0.00211211946768029,0.00384440830215394,-0.00964715973990201,0.00542292080454142,0.582741687055244
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5193.Duration at which refractometer first shown (left),11175,-0.00146569475905126,0.00386734799694799,-0.00904569683306931,0.0061143073149668,0.70470085901574
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5199.logMAR, initial (right)",11267,-0.066707556250643,0.0453783564690158,-0.155649134929914,0.022234022428628,0.141581524172296
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5200.Final number of letters displayed (right),11267,-0.248489663909126,0.215764572437834,-0.671388225887281,0.174408898069029,0.24948102640636
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5201.logMAR, final (right)",11158,-0.00284334373989451,0.00385592783505112,-0.0104009622965947,0.00471427481680568,0.46089741117366
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5202.Number of rounds to result (right),11267,-0.0481668409904869,0.042691588101529,-0.131842353669484,0.0355086716885099,0.259237869337428
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5206.logMAR, initial (left)",11260,-0.0360306711408844,0.0454453420859107,-0.125103541629269,0.0530421993475006,0.427890517341325
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5207.Final number of letters displayed (left),11260,0.132456142834722,0.323417660180896,-0.501442471119833,0.766354756789277,0.682142884648187
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5208.logMAR, final (left)",11149,0.00103250086876632,0.00386138876202636,-0.00653582110480536,0.00860082284233799,0.789173027310954
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5209.Number of rounds to result (left),11254,-0.0623158734750125,0.0435178875564746,-0.147610933085703,0.0229791861356777,0.152183108094125
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",10773,0.00693944996532187,0.00385242394537352,-0.000611300967610234,0.014490200898254,0.0716803768597855
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",10773,0.00701264241567851,0.00383815075328929,-0.000510133060768507,0.0145354178921255,0.0677141008748114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5256.Corneal hysteresis (right),10773,-0.00252331571081228,0.00388730531347076,-0.010142434125215,0.00509580270359041,0.516276652147966
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5257.Corneal resistance factor (right),10773,0.00269548167796026,0.00386961086944956,-0.00488895562616089,0.0102799189820814,0.48608264327382
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",10749,0.00379183205365692,0.00387532722193667,-0.00380380930133895,0.0113874734086528,0.327871545059515
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",10749,0.00446199563229552,0.00384252935697548,-0.00306936190737643,0.0119933531719675,0.245581046479026
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5264.Corneal hysteresis (left),10749,0.00375466726260672,0.00391588666493904,-0.00392047060067379,0.0114298051258872,0.337666289354898
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5265.Corneal resistance factor (left),10749,0.00575598940926574,0.00387955646014284,-0.00184794125261422,0.0133599200711457,0.137925308144535
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11232,-0.0349119284443193,0.207812999990283,-0.442225408425273,0.372401551536635,0.866588789481177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",50016,-0.0109957987231417,0.00994341493209428,-0.0304848919900465,0.00849329454376306,0.268802285051123
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",50016,-0.00630835119937642,0.0108675310426026,-0.0276087120428776,0.0149920096441247,0.561595646868247
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",50016,-0.00808753359955367,0.0103634848566068,-0.0283999639185029,0.0122248967193956,0.435166542322601
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",50016,0.00155525452890826,0.00443044999546829,-0.00712842746220958,0.0102389365200261,0.72556162010099
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",50016,0.000796404394623806,0.00407735898403439,-0.0071952192140836,0.00878802800333121,0.845140424182785
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",22588,0.00129781414744254,0.00503680481112156,-0.00857432328235572,0.0111699515772408,0.796666914566586
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",22588,0.00994288199948651,0.0137048422350134,-0.0169186087811398,0.0368043727801128,0.468152017363344
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",22588,0.000106574549102695,0.00978197118359643,-0.0190660889707463,0.0192792380689517,0.991307318158428
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",22588,-0.00383208158480439,0.00596034055987163,-0.0155143490821528,0.007850185912544,0.520276070950952
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,50167,-0.0192412935440783,0.00681034711884492,-0.0325895738970144,-0.0058930131911423,0.00472545899288621
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,50167,0.0158166816171846,0.00879997976061643,-0.00143127871362361,0.0330646419479928,0.0722854014920361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),50167,0.00423775580594828,0.00675631426572198,-0.0090046201548668,0.0174801317667634,0.530512033778401
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',50167,0.000131602717539604,0.0110870720104324,-0.0215990584229079,0.0218622638579871,0.990529439401888
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),50167,0.0263304204801602,0.0267925891162333,-0.0261830541876571,0.0788438951479775,0.325735171601083
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),50167,-0.00892800616865934,0.0186634577540614,-0.0455083833666196,0.0276523710293009,0.632390191890122
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,50167,0.0324468674217123,0.0291374423018899,-0.0246625194899919,0.0895562543334165,0.265464829442372
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,50015,0.000622689929243631,0.00567602672335743,-0.0105023224485369,0.0117477023070242,0.912643577116669
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,50015,0.0229332297377202,0.00970451216398499,0.00391238589630959,0.0419540735791307,0.0181240784395537
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,50015,0.00780227949268022,0.00508982158040176,-0.00217377080490724,0.0177783297902677,0.125302368832159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,50015,0.00231805839246491,0.00850394925518342,-0.0143496821476946,0.0189857989326244,0.785172520924567
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,50015,-0.0053790742369199,0.00845924779110147,-0.0219591999074788,0.011201051433639,0.524856952368281
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,50015,0.00256158423295052,0.00474948994803015,-0.00674741606518857,0.0118705845310896,0.589655499195783
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,15611,0.00420052620760316,0.0109892696304574,-0.0173384422680933,0.0257394946832996,0.702289387067351
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,15611,-0.00783726995561878,0.0094448291423454,-0.0263491350746158,0.0106745951633782,0.406667520474074
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,15611,-0.0185461710738202,0.0130777562291733,-0.0441785732829998,0.00708623113535949,0.156168046902708
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,15611,0.00629740251946932,0.0104313616845363,-0.0141480663822218,0.0267428714211604,0.546052564930213
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,49957,-0.0093959985290251,0.0143961177795499,-0.037612389376943,0.0188203923188928,0.51396827347733
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#2.Fractured bone site(s)_Leg,49957,-0.018919310615902,0.0213709949601082,-0.0608064607377141,0.0229678395059101,0.376009992159936
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#3.Fractured bone site(s)_Hip,49957,0.00875949450713668,0.038395262497882,-0.0664952199887121,0.0840142090029854,0.819538352152868
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#4.Fractured bone site(s)_Spine,49957,0.00562866100088401,0.0365963591623749,-0.0661002029573707,0.0773575249591388,0.877765018108323
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,49957,-0.0052933798011274,0.0124804952662892,-0.0297551505230543,0.0191683909207995,0.671471236810931
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#6.Fractured bone site(s)_Arm,49957,0.00689393507483305,0.0166257663420023,-0.0256925669554914,0.0394804371051575,0.678397231892221
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,49957,-0.00150523955462465,0.00770191965776253,-0.0166010020838392,0.0135905229745899,0.845051700880345
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16168,0.00793357429414226,0.0120592473230489,-0.0157025504590335,0.031569699047318,0.510622663740485
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16168,0.00389871969288595,0.0130129823616704,-0.0216067257359881,0.02940416512176,0.764484369692353
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16168,-0.00700900356469949,0.0176293170248935,-0.0415624649334908,0.0275444578040918,0.69094758036995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16168,-0.0122223112318294,0.00619381167907045,-0.0243621821228075,-8.24403408513329e-05,0.0484772591623959
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",22744,0.00265663432158088,0.00582215799172479,-0.00875479534219971,0.0140680639853615,0.648180645227451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",22744,0.00548035919472693,0.00568737011206843,-0.00566688622492719,0.0166276046143811,0.335255933015285
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",22744,-0.00314493797487026,0.00519687232685002,-0.0133308077354963,0.00704093178575578,0.545078896159623
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",22745,0.00260613549573125,0.0123053190333964,-0.0215122898097257,0.0267245608011882,0.832273277841922
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",22745,-0.00630495264973239,0.00737203231445979,-0.0207541359860736,0.00814423068660879,0.392420122843853
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",22745,-0.0103409066709192,0.00993166562077892,-0.0298069712876459,0.00912515794580745,0.297791173391214
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,50015,-0.00912166598578111,0.0118613435566892,-0.0323698993568919,0.0141265673853297,0.441882289285011
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,50015,0.00111304959477185,0.00832391883507567,-0.0152018313219765,0.0174279305115202,0.893626886691016
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,50015,-0.00400137546552702,0.0229139957669161,-0.0489128071686826,0.0409100562376286,0.861374360242402
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,50015,-0.00321496360161328,0.00855112588871912,-0.0199751703435028,0.0135452431402762,0.706941072242174
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,50015,-0.0123293478397823,0.00978364108692283,-0.031505284370151,0.00684658869058646,0.207602980897928
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),50015,-0.00307440900594809,0.0112221831304459,-0.0250698879416221,0.018921069929726,0.784117882123014
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,50015,0.00579998175519004,0.00369088173298842,-0.00143414644146727,0.0130341099518473,0.11608790485116
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,9731,-0.0208994631507513,0.0109175764407521,-0.0422979129746254,0.000498986673122842,0.0556117977441156
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,9731,-0.0116416677303142,0.0135927811313765,-0.0382835187478121,0.0150001832871837,0.391764736602699
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,9731,0.0107015047069904,0.00965950420577634,-0.00823112353633125,0.029634132950312,0.267944053634129
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,9731,-0.00659318806050168,0.0086172206726162,-0.0234829405788294,0.0102965644578261,0.444220042813144
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,50244,-0.00126144838259345,0.00431468094264041,-0.00971822303016865,0.00719532626498175,0.770011131767168
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,50244,0.000642406031509686,0.0124123286922016,-0.0236857582052055,0.0249705702682249,0.958723735456439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,50244,-0.00115806923327464,0.00403573189473966,-0.00906810374696437,0.00675196528041508,0.774148759451648
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,50244,0.00141406762893086,0.00390396811740994,-0.00623770988119262,0.00906584513905435,0.717194461160735
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,50244,0.00446821032576853,0.00604105756385097,-0.00737226249937938,0.0163086831509164,0.459521668220728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,50244,-0.00158300708286973,0.00539008473795269,-0.012147573169257,0.00898155900351755,0.768996988580924
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,50244,-0.00374172845882188,0.00419654600833437,-0.0119669586351572,0.00448350171751348,0.372600392713074
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,50244,-0.00490532623657765,0.0124634339936959,-0.0293336568642216,0.0195230043910663,0.693894722768264
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,34767,0.00228166736437567,0.00424937580567645,-0.00604710921475017,0.0106104439435015,0.591311274835595
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,34767,0.00267079348349336,0.00443540379842887,-0.00602259796142723,0.0113641849284139,0.547075959189097
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,34767,-0.00703939614354962,0.00499859698673845,-0.016836646237557,0.00275785395045774,0.159058780250543
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,34768,0.00271771078808861,0.00686133320713116,-0.0107305022978885,0.0161659238740657,0.692040494996449
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,34768,0.000622968348311797,0.00448415546433778,-0.00816597636179025,0.00941191305841384,0.889508977873197
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,49781,-0.00107765476163388,0.00436351290461688,-0.00963014005468296,0.0074748305314152,0.804932818599888
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,49781,0.00257077974155157,0.00347147425177083,-0.00423330979191925,0.00937486927502239,0.45897341222304
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,49781,-0.00219511574289766,0.00385039422955636,-0.00974188843282813,0.00535165694703282,0.568611393178963
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,49781,0.00581144903089704,0.00696647013684145,-0.00784283243731219,0.0194657304991063,0.404170706551379
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),49816,-0.00103359583914214,0.00383397391733744,-0.00854818471712352,0.00648099303883924,0.787477852741669
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,49816,0.00162293702057929,0.00597894527967115,-0.0100957957275762,0.0133416697687347,0.786052207827409
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),50015,-0.00503179377195911,0.00376982231532516,-0.0124206455099964,0.00235705796607821,0.181962225130929
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,50015,-0.0107336458532197,0.00446648271749596,-0.0194879519795118,-0.00197933972692759,0.0162579590205565
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,50015,-0.00626032607961667,0.00673021202818349,-0.0194515416548563,0.00693088949562298,0.35228104341229
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,50015,-0.00696378655716237,0.00855641396011493,-0.0237343579189876,0.0098067848046629,0.415724782201797
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,50015,-0.00265752092540628,0.00931278274244271,-0.020910575100594,0.0155955332497814,0.775367455033632
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,50015,-0.0116349776835646,0.0110709539503239,-0.0333340474261995,0.0100640920590703,0.293288350014004
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",28468,-0.00159161294310337,0.00235213518556188,-0.00620179790680466,0.00301857202059791,0.498622574785509
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X864.Number of days or week walked 10+ minutes,49154,0.0163697273239686,0.0217953280226645,-0.0263491156004539,0.0590885702483911,0.45261660287534
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X874.Duration of walks,42580,0.00321802149414389,0.00186408363244954,-0.000435582425457212,0.006871625413745,0.0842955104629648
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47518,0.0044726234388379,0.0210090864370532,-0.0367051859777865,0.0456504328554622,0.831413712182804
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X894.Duration of moderate activity,36779,0.0441985386362473,0.0258323266143453,-0.00643282152786953,0.0948298988003641,0.0870936377233699
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X90087.No-wear time bias adjusted average acceleration,10475,-0.000994355941928002,0.00383460477250258,-0.00851018129603305,0.00652146941217705,0.795400245715965
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47438,0.0193179527053898,0.0215602060642384,-0.0229400511805175,0.0615759565912972,0.370257111743764
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X914.Duration of vigorous activity,26558,-0.000142355598355696,0.00233089894121601,-0.00471091752313907,0.00442620632642768,0.951301324177073
